Neuroscience Products - ziobio › ICN PDF › neurocatalog › neurocatalog.pdfCATALOG CATALOG NUMBER U.S. $ NUMBER U.S. $ Neuroscience Products One call. One source. 1147 To place

-A-A23187See: Antibiotic A23187

159061 0oC

AA-861 20 mg100 mg

72.70326.40Purity: 95%

Orally active, specific and potent inhibitor of5-lipoxygenase.Ref.: 1. Yoshimoto, T., et.al., Biochim.Biophys. Acta, 713, 470 (1982). 2. Ashida,Y., et.al., Prostaglandins, 26, 955 (1983). 3.Ancill, R.J., et.al., J. Int. Med. Res., 18, 75(1990).C21H26O3 MW 326.4

195876 -70oC

ABL PROTEIN TYROSINE KINASE 250 U 1 KU

47.25162.75(v-abl)

RecombinantExpressed in E. coliA truncated form of the v-abl proteintyrosine kinase which contains theminimum region needed for kinase activityand fibroblast transformation. Suppressesapoptosis and induces resistance toanti-cancer compounds.Activity: 100 KU/mlUnit Definition: one unit is the amount ofenzyme which catalyzes the transfer of 1pmol of phosphate to EAIYAAPFAKKK perminute at 30°C, pH 7.5.Contains no detectable phosphatase andprotease and only trace amounts of RNaseand DNase.MW 45 kDa

193972 0-5oC

ACACETIN 10 mg50 mg

17.5085.00[480-44-4]

(5,7-Dihydroxy-4′-methoxyflavone)Possesses antioxidant properties and aninhibitor of rat liver glutathioneS-transferase.Ref.: Zhang, K. and Das, N.P., Biochem.Pharmacol., 47, 2063 (1994).C16H12O5 MW 284.3

154678 0-5oC

ACETATE KINASE 250 U 1 KU

50.00189.80[9027-42-3]

(ATP: Acetate phosphotransferase)EC 2.7.2.1From Escherichia coliActivity: 150-300 units/mg protein (Biuret).Unit Definition: One unit willphosphorylate 1.0 µmole of acetate toacetylphosphate per min at pH 7.6 at 25°C.Suspension in 3.2 M (NH4)2SO4 solution,pH approx. 6.0.Contains less than 0.01%glutamic-oxalacetic transaminase, lacticdehydrogenase, myokinase and NADHoxidase.

193572 RT

ACETOHEXAMIDE 1 g 5 g

22.0588.20[968-81-0]

(4-Acetyl-N-[(cyclohexylamino)-carbonyl]benzenesulfonamide)Hypoglycemic agentC15H20N2O4S MW 324.4

154683 RT

ACETOPROMAZINE 1 g 10.30[61-00-7](2-Acetyl-10-[3-dimethyl-aminopropyl]phenothiazine)Maleate SaltC19H22N2OS • C4H4O4 MW 442.5

159681 0-5oC

N-[2-(ACETOXY)ETHYL]-3-PYRIDINECARBOXAMIDE

1 mg5 mg

10 mg25 mg

19.0075.00

121.00253.00

(Nicorandil Analog; SG-209)An analog of nicorandil that acts as anitrate-free vasodilator through activation ofpotassium channels.C10H12N2O3 MW 207.2

159549 0-5oC

3-(N-ACETYLAMINO)-5-(N-DECYL-N-METHYLAMINO)BENZYL ALCOHOL

1 mg5 mg

27.5089.40

[103955-90-4](ADMB)A Protein Kinase C activator.Ref.: Proc. Nat. Acad. Sci. USA, 83, 4214(1986).C20H34N2O2 MW 334.5

153036 -20-0oC

N-ACETYL-ASP-GLU 25 mg100 mg250 mg

45.00156.00303.65

[3106-85-2]An endogenous neuropeptide with highaffinity for a brain "Glutamate" receptor.Ref: Zaczek, R., et al., Proc. Natl. Acad.Sci. (USA), 80, 1116 (1983).C11H16N2O8 MW 304.3

N-ACETYL-2-BENZYLTRYPTAMINESee: Luzindole

154690 0oC

ACETYL-DL-CARNITINE 250 mg1 g

60.00214.00[2504-11-2]

HydrochlorideCrystallineC9H17NO4 • HCl MW 239.7

159062 0-5oC

O-ACETYL-L-CARNITINE CHLORIDE 500 mg1 g 5 g

11.4520.6597.45

[5080-50-2](R-(-)-2-Acetyloxy-3-carboxy-N,N,N-trimethyl-1-propanaminium chloride)Purity: >88%A cholinergic agonist that stimulatesneuronal response to serotonin andacetylcholine.C9H18NO4Cl MW 239.7

17032 0-5oC

ACETYLCHOLINE CHLORIDE,[ACETYL-1-14C]

50µCi250µCi

251.35995.00

Sp. Act. 1-10 mCi/mmol37-370 MBq/mmolEthanolRef.: Nicholas, C., et al., J. Neurochem.,62, 1835-1839 (1994).CH3CO2CH2CH2N(CH3)3Cl MW 181.6

100490 0oC

ACETYL COENZYME A 1 mg5 mg

10 mg25 mg

100 mg

11.2527.8550.50

111.15359.00

[72-89-9]Trilithium SaltTrihydratePurity: 92-95%C23H35Li3N7O17P3S • 3H2O MW 881.1

100098 0-5oC

N-ACETYL-L-CYSTEINE 25 g 50 g

100 g 500 g

1 kg

22.0036.7566.25

223.30365.20

[616-91-1]CrystallinePurity: >96%A mucolytic agent for isolation ofmycobacteria from sputum.C5H9NO3S MW 163.2

194603 0-5oC

N-ACETYL-L-CYSTEINE 5 g 10 g 25 g 50 g

100 g 500 g

12.7520.0028.1045.0084.25

260.20

[616-91-1]Cell Culture ReagentCrystallinePurity: >96%A mucolytic agent for isolation ofmycobacteria from sputum.C5H9NO3S MW 163.2

16010 0-5oC

N-ACETYL-L-CYSTEINE, [1-14C] 50 µCi 1332.80Sp. Act. 25-50 mCi/mmol0.925-1.85 GBq/mmolEthanol solution.HSCH2CH(NHCOCH3)COOHMW 163.2

159683 RT

4-ACETYL-1,1-DIMETHYL-PIPERAZINIUM IODIDE

5 mg10 mg25 mg

59.65108.95217.85A nicotinic acid agonist

C8H17N2OI MW 284.1

150229 0oC

N-ACETYLDOPAMINE 10 mg25 mg

100 mg500 mg

16.8033.1090.10

247.20

[2494-12-4]CrystallineMetabolite of dopamineC10H13NO3 MW 195.2

CATALOG CATALOGNUMBER U.S. $ NUMBER U.S. $

Neuroscience Products

To place an order: (800) 854-0530, fax (800) 334-6999 1146 www.icnbiomed.comOutside the U.S.: (714) 545-0100, fax (714) 557-4872 Email: [email protected]

193573 RT

γγγγ-ACETYLENIC GABA 1 mg5 mg

25 mg

11.0044.10

198.45[57659-38-3](4-Amino-5-hexynoic acid)A GABA transaminase inhibitor.Ref.: Schousboe, et al., Neurochem. Res.,11, 1497 (1986).C6H9NO2 MW 127.1

159030 -20oC

N-ACETYL-S-FARNESYL-L-CYSTEINE 5 mg25 mg

71.35306.00(AFC)

Purity: 98%Specific inhibitor of S-farnesyl-cysteinemethyl transferase. Also preventscarboxyl methylation of p21ras platelet RAP1 and the transduction γ subunit.Ref.: 1. Volker, C., et.al., J. Biol. Chem.,266, 21515 (1991). 2. Huzoor-Akabar,et.al., ibid., 266, 4387 (1991). 3.Perez-Sala, D., et.al., Proc. Natl. Acad. Sci.USA, 88, 3043 (1991).MW 367.5

26020 0-5oC

N-ACETYL-S-FARNESYL-L-CYSTEINE, [Cysteine-1-3H]

50 µCi250 µCi

605.151817.90

Sp. Act. 10-20 Ci/mmol370-740 MBq/mmolEthanolShipped in dry ice.Please call for delivery information.MW 367.5

195681 -20oC

N-ACETYL-S-GERANYL-L-CYSTEINE 1 mg5 mg

20.2092.40(AGC)

Purity: 98%A biologically inactive close structuralanalog of AFC and AGGC. Used as anegative control.MW 299.4

159845 -20oC

N-ACETYL-S-GERANYLGERANYL-L-CYSTEINE

5 mg10 mg

131.90229.30

[139332-94-8](AGGC)Purity: 98%Specifically inhibits methyl esterification ofgeranylgeranylated proteins. Also, it blockssignal transduction in human neutrophilsthat are receptor mediated.Ref.: 1. Phillips, M.R., et al., Science, 259,977 (1993).2. Volker, C., et al., FEBS Lett., 295, 189(1991).MW 435.7

158221 -20oC

N-ACETYL-D-GLUCOSAMINYL-ββββ-(1→→→→4)-N-ACETYLMURAMYL-L-ALANYL-D-ISOGLUTAMINE

1 mg5 mg

28.00125.95

(GMDP)Purity: 98%LyophilizedA novel synthetic analog of bacterial cellwall glycopeptide which acts as amodulator of humoral and cellular immunityreactions. Possesses immunoadjuvant andprotective activity against bacterial and viral(including tumorigenic) infections. Differsfrom well-known muramyl peptides in that itcontains GlcNAC attached to muramic acidvia the β-(1→4) glycosidic bond.Soluble in H2O, EtOH, MeOH, DMF, andphysiological saline (1g/ml)Ref.: 1. Campbell, M.J., et al., J.Immunology, 145, 1029 (1990).2. Balitsky, K.P., et al., Int. J.Immunopharmacol., 11, 429 (1989).

100182 0oC

N-αααα-ACETYLGLYCYL-L-LYSINEMETHYL ESTER

100 mg250 mg

1 g 5 g

8.8017.8060.90

280.55[14752-92-2](AGLME)Acetate SaltCrystallineSubstrate for measurement of urokinaseactivity.Ref.: Walton, P.L., Biochem. Biophys. Acta,132, 104 (1967).C11H21N3O4 • C2H4O2 MW 319.4

159684 RT

1-ACETYL-4-METHYLPIPERAZINE 5 mg10 mg25 mg

59.65108.95217.85

HydrochlorideA nicotinic acid agonistC7H14N2O • HCl MW 178.7

194605 0-5oC

N-ACETYLNEURAMINIC ACID 10 mg25 mg

100 mg250 mg500 mg

1 g

12.6525.3566.15

145.55248.05439.90

[131-48-6](Sialic Acid; NANA; Type IV)Cell Culture ReagentFrom E. coliWhite crystalline powderPurity: ≥≥≥≥98%C11H19NO9 MW 309.3

195854 0-5oC


100 mg

10.5037.80

131.25[131-48-6](Sialic Acid; NANA)From Bovine MilkC11H19NO9 MW 309.3

195855 0-5oC


250 mg

12.6052.50

236.25[131-48-6](Sialic Acid; NANA)From EggPurity: ≥≥≥≥97%C11H19NO9 MW 309.3

153039 -20-0oC

N-ACETYL-PHE-NLE-ARG-PHEAMIDE

0.5 mg1 mg5 mg

18.0030.00

131.00[83903-28-0]A molluscan cardioexcitatory neuropeptideanalog.C23H46N8O5 MW 622.8

193574 -20oC

N-ACETYLPROCAINAMIDE 250 mg1 g

11.9537.95[34118-92-8]

(4-(Acetylamino)-N-[2-(diethylamino)ethyl]benzamide)HydrochlorideA metabolite of procainamide that blockspotassium channels and exhibits someantiarrhythmic activity.C15H23N3O2 • HCl MW 313.8

158923 -20oC

N-ACETYL-D-SPHINGOSINE 1 mg5 mg

12.1040.20[3102-57-6]

(C2 Ceramide; N-Ethanoyl-D-sphingosine;Acetyl ceramide)Purity: 98%Inhibitor of cell proliferation and inducer ofmonocytic differentiation of HL-60 cells.Stimulates cytosolic serine/threonineprotein phosphatase in T9 cells at lowconcentrations.Ref.: 1. Kim, M.-Y., et.al., J. Biol. Chem.,266, 484 (1991). 2. Okazaki, T., et.al., ibid.,265, 15823 (1990). 3. Dobrowsky, R.T. andHannun, Y.A., et.al., J. Biol. Chem., 267,5048 (1992).C20H39NO3 MW 341.5

159685 RT

N-ACETYLTRYPTAMINE 5 mg10 mg25 mg

45.9086.00

172.00Useful in determination of serotoninN-acetyl transferaseC12H14N2O MW 202.2

154259 -20oC

ACIVICIN 10 mg100 mg

23.95164.95[42228-92-2]

Purity: 99%Potent irreversible inhibitor ofgamma-glutamyl transpeptidase(ID50=0.54mM).Potent anti-tumor agent.C5H7ClN2O3 MW 178.6



One call. One source. 1147 To place an order: (800) 854-0530, fax (800) 334-6999A world of biomedical products. Outside the U.S.: (714) 545-0100, fax (714) 557-4872

154710 RT

ACONITINE 25 mg100 mg

60.00220.00[302-27-2]

Purity: 95%CrystallineC34H47NO11 MW 645.7

104658 0-5oC

ACTINOMYCIN D 1 mg5 mg

10 mg25 mg50 mg

100 mg

15.0065.0099.00

205.00315.00545.75

[50-76-0]CrystallinePurity: ∼∼∼∼98%Potent apoptosis inducer.Soluble in chloroform, acetone, methanoland decomposed by strong acids, light.C62H86N12O16 MW 1255.5

194525 0-5oC


10 mg25 mg

40.2061.50

115.75240.35

[50-76-0]Cell Culture ReagentCrystallinePurity: ∼∼∼∼98%Inhibits nucleic acid synthesis and potentlyinduces apoptosis.C62H86N12O16 MW 1255.5

196035 0-5oC


25 mg

11.5548.85

179.00[50-76-0]From Streptomyces parvulusPurity: ∼∼∼∼98%Potent apoptosis inducer and nucleic acidsynthesis inhibitor.Soluble in methanol.C62H86N12O16 MW 1255.5

105460 0oC

ADENOSINE-3′′′′,5′′′′-cyclic-MONOPHOSPHATE

25 mg100 mg500 mg

1 g

11.4528.4589.45

166.40[37839-81-9](Adenosine-3′,5′-Monophosphoric Acid)Sodium SaltCrystallinePurity: Approx. 98%C10H11N5O6PNa MW 351.2

100056 0oC

ADENOSINE-5′′′′-DIPHOSPHATE 100 mg500 mg

1 g 5 g

8.0528.9547.30

152.80

[16178-48-6](ADP-Na2)From Equine MusclePurity: ≥≥≥≥95%White to off-white powderDisodium SaltC10H13N5Na2O10P2 MW 471.2

100080 0oC

ADENOSINE-5′′′′-MONOPHOSPHATE 1 g 5 g

25 g 100 g

6.7021.3051.40

153.70

[18422-05-4]From YeastFree AcidCrystallinePurity: 99-100%C10H14N5O7P MW 347.2

150264 0oC

ADENOSINE-5′′′′-MONOPHOSPHATE 1 g 5 g

25 g 100 g

7.1018.2083.40

301.40

[4578-31-8](AMP)From YeastDisodium SaltCrystallinePurity: 99-100%C10H12N5Na2O7P MW 391.2

159550 0oC

ADENOSINE-5′′′′-O-THIOMONOPHOSPHATE

1 mg5 mg

28.4594.30

[93839-85-1](AMP-S)Dilithium SaltActs as substrate and inhibitor forAMP-dependent enzyme systems.Ref.: Murray, A.W. and Atkinson, M.R.,Biochemistry, 7, 4023 (1968).C10H12N5O6PSLi2 MW 375.1

159551 -20oC

ADENOSINE-5′′′′-O-(3-THIOTRIPHOSPHATE)

1 mg5 mg

26.9089.60

[93839-89-5](ATP-γ-S)Tetralithium SaltPurity: >80%Ref.: Chrysogelos, S., et al., J. Biol. Chem.,258, 12624 (1983).C10H12N5O12P3SLi4 MW 547.0

100004 0oC

ADENOSINE-5′′′′-TRIPHOSPHATE 500 mg1 g 5 g

15.4025.00

118.80[42373-41-1]Dipotassium SaltPurity: >96%C10H14N5O13P3K2 MW 583.4

100008 0oC

ADENOSINE-5′′′′-TRIPHOSPHATE 1 g 5 g

10 g 25 g

100 g

12.3038.0561.50

135.30439.30

[51963-61-2](ATP)Disodium SaltCrystallinePurity: Approx. 99%C10H14N5Na2O13P3 MW 551.2

194613 0oC

ADENOSINE-5′′′′-TRIPHOSPHATE 1 g 5 g

10 g

20.6052.6094.80

[51963-61-2](ATP)Disodium SaltCell Culture ReagentCrystallinePurity: ∼∼∼∼99%C10H14N5Na2O13P3 MW 551.2

195879 0-5oC

ADENYLATE CYCLASE ACTIVATINGPEPTIDE-27

25 µg100 µg

47.25131.25

[127317-03-7](PACAP-27)His-Ser-Asp-Gly-Ile-Phe-Thr-Asp-Ser-Tyr-Ser-Arg-Tyr-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Ala-Ala-Val-Leu-NH2Purity: ≥≥≥≥97%MW 3147.6

195880 0-5oC

ADENYLATE CYCLASE ACTIVATINGPEPTIDE, Fragment 6-27

100 µg 89.25

[136134-68-4]Phe-Thr-Asp-Ser-Tyr-Ser-Arg-Tyr-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Ala-Ala-Val-Leu-NH2Purity: ≥≥≥≥97%Inhibits PACAP-27MW 2638.1

195881 0-5oC

ADENYLATE CYCLASE ACTIVATINGPEPTIDE-38

100 µg 189.00

[137061-48-4](PACAP-38)His-Ser-Asp-Gly-Ile-Phe-Thr-Asp-Ser-Tyr-Ser-Arg-Tyr-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Ala-Ala-Val-Leu-Gly-Lys-Arg-Tyr-Lys-Gln-Arg-Val-Lys-Asn-Lys-NH2More potent than VIP at stimulatingadenylate cyclase.MW 4534.3

193589 0-5oC

ADRENALINE ELISA KIT 1 each 468.55This adrenaline ELISA kit providesmaterials for the quantitative measurementof chemically derivatized adrenaline inurine. The assay procedure follows thebasic principle of competitive ELISAwhereby there is competition between abiotinylated and non-biotinylated antigen fora fixed number of antibody binding sites.The kit is a 12 x 8 well format.

FOR RESEARCH USE ONLY!

AEBSFSee: 4-(2-Aminoethyl)-benzenesulfonylfluoride

AG-126See: Tyrphostin A10




AG-370See: Tyrphostin B7




195715 RT

AG-879 1 mg5 mg

23.60100.80Purity: 99%

A tyrphostin family member which inhibitsthe NGF receptor autophosphorylationselectively with no inhibition of EGF orPDGF receptor phosphorylation. InhibitsNGF-induced neurite outgrowth in PC12cells.MW 316.5

100274 0oC

AGMATINE SULFATE 250 mg1 g

20.0074.85[2482-00-0]

(4-Guanidinobutane sulfate; Argamine)Purity: 95-97%This is the enzymatic decarboxylationproduct of arginine, which acts as animidazoline receptor agonist.C5H14N4 • H2SO4 MW 228.3

193575 RT

AGROCLAVINE 10 mg25 mg

100 mg

11.0022.0579.40

[548-42-5](8,9-Didehydro-6,8-dimethylergoline)An ergot alkaloid which acts as a dopaminereceptor agonist.C16H18N2 MW 238.3

159009 0-5oC

ALAMETHICIN 5 mg10 mg25 mg

59.65113.50271.15

[27061-78-5](Antibiotic U-22324)Mixture of alamethicin homologs. Antibioticwhich increases the permeability ofmembranes. Also increases theincorporation of 32P into phosphatidylinositol4-phosphate and sarcoplasmic reticulumvesicles permeability.Ref.: 1. Brewer, D., et.al., Can. J.Microbiol., 33, 619 (1987). 2. Quist, E.,et.al., Arch. Biochem. Biophys., 271, 21(1989).

193576 RT

ALAPROCLATE 10 mg25 mg

100 mg

16.5533.05

121.25[60719-83-7](DL-Alanine2-(4-chlorophenyl)-1,1-dimethylethyl ester)HydrochloridePowerful, selective serotonin uptakeinhibitor.C13H18NO2Cl • HCl MW 292.2

159010 0-5oC

ALLETHRIN 10 mg25 mg50 mg

35.8085.40

166.55[584-79-2](Allethrin I)Mixture of 8 isomersA Type I pyrethrin which demonstrates veryweak active "negative" control properties forcalcineurin (protein phosphatase 2B)inhibition by Type II pyrethrins.C19H26O3 MW 302.42

195886 RT

ALLOPREGNANOLONE 1 mg5 mg

26.25110.25[516-54-1]

(Allopregnan-3α-ol-20-one;3α-Hydroxy-5α-20-one)Purity: ≥≥≥≥95%A neurosteroid with potent ligand propertiesagainst GABA Type A receptor complexesin mammalian CNS potentiating the GABAreceptor-mediated chloride uptake insynaptoneurosomes.C21H34O2 MW 318.5

193577 RT

1-ALLYL-3,7-DIMETHYL-8-PHENYLXANTHINE

5 mg10 mg25 mg

35.3066.15

132.30[149981-23-7]An A1 Adenosine receptor antagonist.Ref.: Jacobson, et al., J. Med. Chem.,38(18), 2639 (1993).C16H16N4O2 MW 296.3

159860 RT

3-(4-ALLYLPIPERAZIN-1-YL)-2-QUINOXALINECARBONITRILE

5 mg10 mg

98.60166.25

Purity: 98%Selective antagonist of serotonin 5-HT3.Ref.: Monge, A., et al., J. Med. Chem., 36,2745 (1993).MW 395.4

193579 RT

ALPHAXALONE 1 mg5 mg

10 mg

16.5555.1099.20

[23930-19-0](3α-Hydroxy-5α-pregnane-11,20-dione)A neurosteroid which acts upon the GABAAreceptor.Ref.: Turner, et al., J. Pharmacol. Exp.Ther., 248, 960 (1989).C21H32O3 MW 332.5

190092 RT

L-ALPRENOLOL 1 g 5 g

25 g

13.7044.95

149.65[13707-88-5](L-1[2-Allylphenoxy]-3-isopropyl-aminopropan2-ol)HydrochlorideCrystallineHydrateC15H23NO2 • HCl • H2O MW 303.8

159778 RT

ALRESTATIN 5 mg10 mg25 mg

45.9084.85

169.70[51411-04-2](1,3-Dioxo-IH-benz[de]isoquinoline-2(3H)-acetic acid)Aldose reductase inhibitor.C14H9NO4 MW 255.2

159552 RT

ALUMINUM CHLORIDE 100 g 500 g

1 kg

8.8531.0057.00

[7784-13-6](Aluminum trichloride)HexahydrateOften used in aqueous solution with NaF toinduce a number of biological effects fromgeneration of the (AlF4-) moiety.AlCl3 • 6H2O MW 241.4

159687 RT

AMBENONIUM DICHLORIDE 5 mg10 mg25 mg

59.65108.95217.85

[52022-31-8]A reversible, noncovalent inhibitor of acetylcholinesterase.C28H42N4O2Cl4 MW 608.5

153650 0-5oC

AMFONELIC ACID 5 mg10 mg25 mg

25.0545.05

100.15[15180-02-6](7-Benzyl-1-ethyl-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid)Dopamine releaserC18H16N2O3 MW 308.3

194099 0-5oC

AMIDINOPHENYL BENZOATE 10 mg100 mg

16.5555.10(APB; Try Inhibitor)

HydrochlorideA trypsin-like serine protease inhibitor.Ref.: Markwardt, F., et al., Acta Biol. Meg.Germ., 28, k19-k25 (1972).

194956 0-5oC

p-AMIDINOPHENYLMETHYL-SULFONYLFLUORIDE

1 mg5 mg

18.0062.40

[74938-88-8](p-APMSF)HydrochloridePurity: >75%A stable, non-toxic alternative to DFP orPMSF. Specifically and irreversibly inhibitstrypsin-like serine proteases, trypsin, andthrombin. Demonstrates activity on factorXa, plasmin, C1r and C1s. Activity is 1000fold greater than PMSF.Ref.: Cole, T.C., et al., Biochim. Biophys.Acta, 990, 254 (1989).MW 257.2




194100 0-5oC

AMIDINOPHENYLPYRUVIC ACID 1 mg10 mg25 mg

12.6576.05

165.35(APPA)A polyvalent inhibitor for serine proteaseslike trypsin, factor IIa, factor Xa, and plasmakallikrein. It is a potent acrosin inhibitor, aswell as, an effective inhibitor of thrombinand factor Xa clotting activity. It candistinguish between plasma kallikrein andglandular kallikrein, thrombin, andbatroxobin (thrombin-like snake venomenzyme).Ref.: Geratz, J.D., Arch. Biochem.Biophys., 118, 90-6 (1967).

153537 RT

AMILORIDE 50 mg250 mg

1 g

14.8536.1572.25

[2016-88-8](3,5-Diamino-N-(aminomethyl)-6-chloropyrazinecarboxamide)HydrochlorideA sodium ion channel inhibitorC6H8ClN7O • HCl MW 266.1

195856 0-5oC

7-AMINOACTINOMYCIN D 1 mg 65.70[7240-37-1](7-AAD; 7-Amino-AMD; 7-Actinomycin C1;7-Aminodactinomycin)Purity: ≥≥≥≥95%DNA intercalator and growth inhibitoragainst certain forms of leukemia andsarcomas.MW 1270.4

159028 RT

3-AMINOBENZAMIDE 100 mg250 mg

1 g 5 g

25.6049.70

133.95530.00

[3544-24-9](PARP Inhibitor)Purity: 97%Endogenous poly-ADP-ribosyltransferaseinhibitor.Ref.: Kozak, K.R. and Ross, I.A., Biochem.Biophys. Res. Commun., 179, 1225 (1991).C7H8N2O MW 136.2

159861 RT

1-AMINOBENZOTRIAZOLE 20 mg50 mg

100 mg

30.0070.00

130.60[1614-12-6]Purity: 99%Suicide inhibitor of cytochrome P-450 andchloroperoxidase. Oxidative drugmetabolism inhibitor in in vivo studies.Ref.: 1. Matthews, J.M., et al., J.Pharmacol. Exp. Ther., 235, 186 (1985).2. Mico, B.A., et al., Biochem. Toxicol., 37,2515 (1988).3. Mugford, C.A., et al., Fundam. Appl.Toxicol., 19, 43 (1992).C6H6N4 MW 134.1

195664 0-5oC

p-AMINOBENZOYL-GLY-PRO-D-LEU-D-ALA-HYDROXAMIC ACID

1 mg5 mg

20.0084.20

[124168-73-6]Purity: 97%Broad spectrum protease inhibitor againsthuman matrix metalloproteinase,collagenase, gelatinase and stromelysin.C23H34N6O6 MW 490.6

193738 RT

AMINOBENZTROPINE 5 mg25 mg

100 mg

16.5555.10

198.45(3-(2′-Aminobenzhydryloxy)tropane)Muscarinic ligand with very high affinity.Useful for solubilizing muscarinic receptors.Ref.: Haga, et al., J. Biol. Chem., 258,13575 (1983).C21H26N2O MW 322.4

159690 0-5oC

N-(4-AMINOBUTYL)-5-CHLORO-2-NAPHTHALENESULFONAMIDE

1 mg5 mg

10 mg

55.20218.50393.65[88519-57-7]

(W-13)HydrochlorideA calmodulin antagonistRef.: Stroble and Peterson, J. Pharm. Exp.Ther., 263, 186 (1992).C14H17N2O2SCl • HCl MW 349.3

159691 0-5oC

N-(4-AMINOBUTYL)-2-NAPHTHALENESULFONAMIDE

1 mg5 mg

10 mg

55.25218.60393.65[89108-46-3]

(W-12)HydrochlorideA calmodulin antagonist.Ref.: Hidaka, et al., Proc. Nat. Acad. Sci.USA, 78, 4354 (1981).C14H18N2O2S • HCl MW 314.8

16011 0-5oC

γγγγ-AMINOBUTYRIC ACID, [4-14C] 50 µCi250 µCi

447.501150.90Sp. Act. 50-60 mCi/mmol

1.85 -2.22 GBq/mmol0.01N HCl solution.Please call for delivery information.H2NCH2(CH2)2COOH MW 137.0

100278 RT

γγγγ-AMINO-n-BUTYRIC ACID 10 g 25 g

100 g 500 g

1 kg

6.859.85

23.6093.50

152.90

[56-12-2](GABA; 4-Aminobutanoic acid)CrystallinePurity: Approx. 99%C4H9NO2 MW 103.1

693281 0-5oC

γγγγ-AMINOBUTYRIC ACIDMONOCLONAL ANTIBODY

10 µg 86.20

Anti-GABAClone: AD5A9Isotype: mouse IgG1 presented affinitypurifiedConc/Titer: 100 µg/mlApplications: ImmunohistochemistryThe original immunogen was GABAcoupled to BSA. The antibody is highlyspecific to GABA, a non-protein amino acidneurotransmitter, and does not react withother amino acids.

5-AMINO-3-(3-CHLORO-2-METHYLPHENYL)-1,2,3,4-OXA-TRIAZOLIUMSee: GEA 5024

159693 RT

3-AMINO-2-(4-CHLOROPHENYL)-2-HYDROXYPROPANESULFONIC ACID

1 mg5 mg

10 mg

20.0075.00

142.80[117354-64-0](2-Hydroxysaclofen)Purity: 98% min.Selective antagonist at GABAB receptors.Also see PhaclofenC9H12NO4SCl MW 265.7

159692 RT

3-AMINO-2-(4-CHLOROPHENYL)-PROPANE SULFONIC ACID

1 mg5 mg

10 mg

28.65114.65217.85[125464-42-8]

(Saclofen)Selective antagonist at GABAB receptors.C9H12NO3SCl MW 249.7

3-AMINO-2-(4CHLOROPHENYL)PROPANE-PHOS-PHONIC ACIDSee: Phaclofen

153649 0-5oC

p-AMINOCLONIDINE 1 mg5 mg

10 mg

23.9578.35

129.90[73217-88-6]Hydrochlorideα2-Adrenergic receptor agonistC9H10Cl2N4 • HCl MW 281.5

159694 -20oC

cis-4-AMINOCROTONIC ACID 1 mg5 mg

28.65114.65[55199-25-2]

(Z-4-Amino-2-butenoic acid)An analog of GABA. Used as a probe forbicuculline-insensitive GABA receptors.C4H7NO2 MW 101.1

159695 RT

trans-4-AMINOCROTONIC ACID 1 mg5 mg

25 mg

17.2063.05

252.25[38090-53-8](E-4-Amino-2-butenoic acid)Potent bicuculline-sensitive GABA agonistand GABA uptake inhibitor.C4H7NO2 MW 101.1




159696 RT

1-AMINOCYCLOBUTANE-CARBOXYLIC ACID

5 mg10 mg50 mg

29.8053.00

212.10[22264-50-2]A specific NMDA receptor antagonist whichacts at the glycine site.Ref.: Hood, et al., Eur. J. Pharmacol., 161,281 (1989).C5H9NO2 MW 115.1

158856 RT

1-AMINOCYCLOBUTANE-cis-1,3-DICARBOXYLIC ACID

1 mg5 mg

10 mg25 mg

15.5070.00

120.00286.00

[117488-23-0](trans-1-Aminocyclobutane-1,3-dicarboxylicacid, IUPAC name)MonohydratePurity: ≥≥≥≥99%The most potent and highly selectivesynthetic NMDA agonist known.Ref.: 1. Lanthorn, T.H., et.al., Eur. J.Pharmacol., 182, 397 (1990). 2. Allen, R.D.,et.al., J. Med. Chem., 33, 2905 (1990).Note: Some confusion exists concerningthe name of this item, due to contradictionsin the literature. This isomer has the twocarboxyl groups on the same side of thecyclobutyl ring.C6H9NO4 • H20 MW 177.16

159702 RT

(±±±±)-1-AMINOCYCLOPENTANE-cis-1,2-DICARBOXYLIC ACID

1 mg5 mg

10 mg

21.2084.85

158.20A structural analog of (±)-1-Amino-cyclopentane-cis-1,3-dicarboxylic acid.C7H11NO4 MW 173.2

159704 RT

(±±±±)-1-AMINOCYCLOPENTANE-cis-1,3-DICARBOXYLIC ACID

1 mg5 mg

10 mg

20.0095.00

183.60[39026-63-6]Potent NMDA agonist. A 1:1 mixture of(1R,3R) & (1S,3S)-enantiomers.C7H11NO4 MW 173.2

159705 RT

(±±±±)-1-AMINOCYCLOPENTANE-trans-1,3-DICARBOXYLIC ACID

1 mg5 mg

10 mg

33.2580.00

153.00[39026-64-7]Glutamate receptor agonist. A 1:1 mixtureof (1R,3R) & (1S,3S)-enantiomers.C7H11NO4 MW 173.2

26021 0-5oC

(±±±±)-1-AMINOCYCLOPENTANE-trans-1,3-DICARBOXYLIC ACID, [4,5-3H]

250µCi1mCi

1090.252060.45

Sp.Act. 200-300 mCi/mmol7.4-11.1 GBq/mmolEthanol: water solution (2.8)HPLC Analyzed for Purity.Please call for delivery information.HOCH2(CHOH)3COCH2OH MW 180.2

5-AMINO-3-(3,4-DICHLOROPHENYL)-1,2,3,4-OXATRIA-ZOLIUMSee: GEA 3162

3-AMINO-2,4-DICYANO-5-(4-HYDROXYPHENYL)PENTA-2,4-DIENONITRILESee: Tyrphostin A48

158857 0oC

(±±±±)-3-AMINO-2,3-DIHYDROBENZOICACID

10 mg25 mg50 mg

34.9580.00

147.00[59556-17-1](Gabaculine HCl)HydrochlorideAn irreversible potent inhibitor ofγ-aminobutyric acid transaminase.Ref.: 1. Metcalf, B.W., Biochem.Pharmacol., 28, 1705 (1979).2. Loscher, W., Naunyn-Schmiedeberg’sArch. Pharmacol., 315, 119 (1980).C7H9NO2 • HCl MW 175.6

153647 0-5oC

(±±±±)-2-AMINO-6,7-DIHYDROXY-1,2,3,4-TETRAHYDRONAPHTHALENE

10 mg15 mg25 mg

51.0572.95

115.70[73304-33-3](6,7-ADTN HBr)HydrobromideDopamine agonistC10H13NO2 • HBr MW 260.2

193503 RT

4-(2-AMINOETHYL)BENZENE-SULFONYL FLUORIDE

10 mg50 mg

100 mg500 mg

1 g

11.0031.9554.50

207.05300.00

[30827-99-7]Hydrochloride(AEBSF)Purity: 97% (HPLC)A covalent binding serine protease inhibitor.AEBSF belongs to the family of irreversiblesulfonyl fluoride inhibitors that block trypsinand chymotrypsin-type enzymes. Similar instructure to the commonly used inhibitorPMSF, AEBSF offers better solubility inwater, lower toxicity, greater stability andhigher inhibitory activity.C6H10FNO2S • HCl MW 239.7

159707 RT

N-(2-AMINOETHYL)-4-CHLOROBENZAMIDE

10 mg50 mg

100 mg

13.7540.1068.75[94319-79-6]

(Ro 16-6491)HydrochlorideA monoamine oxidase-β inhibitor.C9H11N2OCl • HCl MW 235.1

158858 0oC

N-(2-AMINOETHYL)-5-CHLORO-NAPHTHALENE-1-SULFONAMIDE

10 mg25 mg50 mg

57.85137.60263.70(A-3)

Purity: 98%Inhibitor of PKA, PKG, MLCK, and proteinkinase C.Ref.: Inagaki, M., et.al., Mol. Pharmacol.,29, 577 (1986).MW 321.2

159709 0-5oC

N-(2-AMINOETHYL)-3-IODOBENZAMIDE

1 mg5 mg

10 mg25 mg

13.7552.7597.45

215.00HydrochlorideReported to be a stronger MAO-β inhibitorthan N-(2-Aminoethyl)-4-chlorobenzamide.Ref.: Annan and Silverman, J. Med. Chem.,36, 3968 (1993).C9H11N2OI • HCl MW 326.6

158859 0oC

N-(2-AMINOETHYL)-5-ISOQUINOLINESULFONAMIDE

10 mg25 mg50 mg

68.75157.65286.65[84468-17-7]

(H-9)DihydrochloridePurity: 99%Excellent for chromatographic purification ofprotein kinases. Protein kinase inhibitor.Ref.: 1. Hidaka, H., et.al., Biochemistry, 23,5036 (1984). 2. Inagaki, M., et.al., J. Biol.Chem., 260, 2922 (1985). 3. Wolf, M., et.al.,ibid., 260, 15718 (1985).C11H13N3O2S • 2HCl MW 324.3

159710 RT

2-AMINOETHYLPHOSPHONIC ACID 100 mg250 mg

20.0033.45[2041-14-7]

C2H8NO3P MW 125.1

2-AMINOETHYLSULFINIC ACIDSee: Hypotaurine

153645 RT

(±±±±)-p-AMINOGLUTETHIMIDE 25 mg50 mg

100 mg

14.4523.9543.35

[125-84-8]Inhibitor of cytochrome P-450-dependenthydroxylation reactions.C13H16N2O2 MW 232.3

153643 RT

R(+)-p-AMINOGLUTETHIMIDETARTRATE

15 mg25 mg50 mg

25.3539.8072.25[57344-88-4]

An active enantiomer ofp-aminoglutethimide.C13H16N2O2 • C4H6O6 MW 382.4




153644 RT

S(-)-p-AMINOGLUTETHIMIDETARTRATE

15 mg25 mg50 mg

25.3539.8072.25(S(-)-3-(4-Aminophenyl)-3-ethyl-2,6-piperidine

dione tartrate)An enantiomer of p-aminoglutethimidewhich is less active.C13H16N2O2 • C4H6O6 MW 382.4

150349 RT

AMINOGUANIDINE BICARBONATE 100 g 500 g

9.2524.00[2582-30-1]

(Guanylhydrazine bicarbonate)CrystallineCH6N4 • H2CO3 MW 136.1

154186 0-5oC

N-(6-AMINOHEXYL)-5-CHLORO-1-NAPHTHALENESULFONAMIDE

25 mg100 mg250 mg

25.4082.25

167.00[61714-27-0](W7)HydrochloridePurity: ≥≥≥≥98%W7 is a vascular relaxing agent whichaffects vascular smooth muscleactomyosin. W7 is also a calmodulinantagonist that binds to calmodulin andinhibits Ca2+ calmodulin-regulated enzymeactivities.C16H21ClN2O2S • HCl MW 377.3

154743 0-5oC

N-(6-AMINOHEXYL)-5-CHLORO-2-NAPHTHALENESULFONAMIDE

1 mg5 mg

10 mg

55.25148.50267.80[69762-85-2]

HydrochlorideA calmodulin antagonistRef.: Hidaka, H., et al., Proc. Nat. Acad.Sci. USA, 78, 4354 (1981).C16H21ClN2O2S • HCl MW 377.3

154744 0-5oC

N-(6-AMINOHEXYL)-1-NAPHTHALENESULFONAMIDE

1 mg5 mg

45.95180.80

[61714-25-8](W5)HydrochlorideReported to be a calmodulin antagonist.Ref.: Hidaka, H., et al., Proc Nat. Acad.Sci. USA, 78, 4354 (1981).C16H22N2O2S • HCl MW 342.9

154745 0-5oC

N-(6-AMINOHEXYL)-2-NAPHTHALENESULFONAMIDE

1 mg5 mg

34.90138.70

[35517-14-7]HydrochlorideRef.: Hidaka, H., et al.,Proc Nat. Acad. Sci. USA, 78, 4354 (1981).C16H22N2O2S • HCl MW 342.9

4-AMINO-5-HEXYNOIC ACIDSee: γ-Acetylenic GABA

159712 RT

(±±±±)-αααα-AMINO-3-HYDROXY-5-METHYL-ISOXAZOLE-4-PROPIONIC ACID

1 mg5 mg

10 mg

33.85137.60258.00(AMPA)

DihydrateSelective quisqualate-like agonist.C7H10N2O4 • H2O MW 220.2

154747 0-5oC

(±±±±)-αααα-AMINO-3-HYDROXY-5-METHYL-ISOXAZOLE-4-PROPIONIC ACID

1 mg5 mg

10 mg

43.25189.20344.00[118896-96-1]

(AMPA)HydrobromidePotent quisqualate-like agonistRef.: 1. Krogsgaard-Larsen, P., et al.,Nature (London), 284, 64 (1980). 2.Honore, T., et al., J. Neurochem., 38, 173(1982).C7H10N2O4 • HBr MW 267.1

158860 RT

7-AMINOKETANSERIN 25 mg50 mg

321.05584.75(R 63234)

Purity: 99%Affinity ligand for 5-HT and histaminereceptors.Ref.: 1. Wouters, W., et.al., Biochem.Pharmacol., 35, 3199 (1986). 2. Wouters,W., et.al., FEBS, 182, 291 (1985). 3.Wouters, W., et.al., J. Biol. Chem., 260,8423 (1985).MW 410.4

159713 -20oC

AMINOMALONIC ACID 1 mg5 mg

25 mg

13.7538.95

155.90[1068-84-4]C3H5NO4 MW 119.1

195935 -20oC

2′′′′-AMINO-3′′′′-METHOXYFLAVONE 1 mg5 mg

26.2599.75(PD 98059)

Purity: >95%MAP kinase activation inhibitor. Inhibits cellgrowth and reverses the phenotype ofras-transformed BalB 3T3 fibroblasts.C16H13NO3 MW 267.3

154187 0-5oC

αααα-AMINO-ββββ-METHYLAMINO-PROPIONIC ACID

10 mg50 mg

100 mg

27.0094.70

159.80Hydrochloridemp 165-167°CPurity ≥≥≥≥98%An amino acid isolated from the seeds ofCycas Circinalis that is neurotoxic to higheranimals.C4H11O2N2 • HCl MW 155.5

196027 RT

4-AMINO-1,8-NAPHTHALIMIDE 5 mg25 mg

21.0078.75[1742-95-6]

(PARP Inhibitor)Purity: ≥≥≥≥96%Reduces ischemia-reperfusion injury in theheart and skeletal muscles.MW 212.2

195709 -20oC

1,2-bis(o-AMINOPHENOXY)ETHANE-N,N,N′′′′,N′′′′-TETRAACETIC ACIDTETRAACETOXYMETHYL ESTER

25 mg 136.50

[126150-97-8](BAPTA-AM)Purity: >90%A cell permeable derivative of BAPTAwidely used as an intracellular calciumsponge.C34H40N2O18 MW 764.7

158861 RT

D-(-)-2-AMINO-4-PHOSPHONO-BUTYRIC ACID

1 mg5 mg

30.00123.90

[78739-01-2](D-(-)-2-Amino-4-phosphono-butanoic acid; D-AP4)Purity: 98%NMDA antagonist.Ref.: Davies, J. and Watkins, J.C., BrainRes., 235, 378 (1982).C4H10NO5P MW 183.1

158862 RT

L-(+)-2-AMINO-4-PHOSPHONO-BUTYRIC ACID

1 mg5 mg

49.30114.80

[23052-81-5](L-(+)-2-Amino-4-phosphono-butanoic acid; L-AP4)Purity: 99%NMDA agonist and synaptic depressant.Ref.: 1. Davies, J. and Watkins, J.C., BrainRes., 235, 378 (1982). 2. Koerner, J.F. andCotman, C.W., Brain Res., 216, 192 (1981).C4H10NO5P MW 183.1

153641 RT

(±±±±)-2-AMINO-4-PHOSPHONO-BUTYRIC ACID

25 mg50 mg

100 mg

26.1046.3086.75[20263-07-4]

(DL-2-Amino-4-phosphono-butanoic acid; AP-4)Purity: 99%C4H10NO5P MW 183.1




26023 0-5oC

L-(+)-AMINO-4-PHOSPHONO-BUTYRIC ACID, [2,3-3H]

250 µCi1 mCi

1091.352060.45

(AP 4)Sp. Act. 40-60 Ci/mmol1.48-2.22 TBq/mmolEthanol:water (1:1)Shipped in dry ice.Please call for delivery information.MW 183.1

153640 0-5oC

(±±±±)-2-AMINO-7-PHOSPHONO-HEPTANOIC ACID

2 mg5 mg

10 mg

31.8062.20

115.70[85797-13-3](AP-7)NMDA antagonistC7H16NO5P MW 225.2

158863 RT

D-(-)-2-AMINO-5-PHOSPHONO-PENTANOIC ACID

1 mg 49.30

[79055-68-8](D-(-)-2-Amino-5-phosphono-valeric acid; D-AP5)Purity: 99%Active form of AP5, and a competitiveNMDA antagonist.Ref.: 1. Watkins, J.C., et.al., Ann. Rev.Pharmacol. Toxicol., 21, 165 (1981). 2.Hansen, J.J. and Krogsgaard-Larsen, P.,Med. Res. Rev., 10, 55 (1990).C5H12NO5P MW 197.1

158864 RT

L-(+)-2-AMINO-5-PHOSPHONO-PENTANOIC ACID

1 mg5 mg

36.40131.90

[79055-67-7](L-(+)-2-Amino-5-phosphono-valeric acid; L-AP5)Purity: 99%Less active form than AP5.Ref.: 1. Watkins, J.C., et.al., Ann. Rev.Pharmacol. Toxicol., 21, 165 (1981). 2.Hansen, J.J. and Krogsgaard-Larsen, P.,Med. Res. Rev., 10, 55 (1990).C5H12NO5P MW 197.1

153639 RT

(±±±±)-2-AMINO-5-PHOSPHONO-PENTANOIC ACID

2 mg5 mg

10 mg

23.1530.0051.00[76326-31-3]

(AP-5; DL-2-Amino-5-phosphono-valeric acid)Potent NMDA antagonistC5H12NO5P MW 197.04

26054 0-5oC

D-(-)-AMINO-5-PHOSPHONO-PENTANOIC ACID, [4,5-3H]

250 µCi1 mCi

842.851758.50

(AP 5)Sp. Act. 20-40 Ci/mmol0.74-1.48 TBq/mmolEthanol:water (1:1)Shipped in dry ice.Please call for delivery information.MW 197.13

159720 RT

N-(3-AMINOPROPYL)-CYCLOHEXANAMINE

1 mg5 mg

25 mg

13.7542.40

169.70[3312-60-5]DihydrochlorideInhibitor of spermine and spermidinesynthases.Ref.: Chu, et al., Eur. J. Pharm., 256, 155(1994).C9H20N2 • 2HCl MW 229.2

159862 RT

2-AMINOPURINE 25 mg100 mg250 mg500 mg

10.1052.95

109.00204.00

[452-06-2](2-AP)Purity: 98%Selective protein kinase inhibitor active onp58 PITSLREβ1 (a p34cdc2-related proteinkinase) which may be used to overridemultiple cell cycle checkpoints anddrug-induced cell cycle blocks.Ref.: 1. Andreassen, P.R. and Margolis,R.L., Proc. Natl. Acad. Sci. USA, 89, 2272(1992).2. Xiang, J., et al., Biochem. Biophys. Res.Commun., 199, 1167 (1994).C5H5N5 MW 135.1

150366 RT

4-AMINOPYRIDINE 5 g 10 g 25 g

100 g

5.007.60

15.2552.45

[504-24-5]Purity: ∼∼∼∼98%Pink to red crystalsC5H6N2 MW 94.1

154198 0-5oC

9-AMINO-1,2,3,4-TETRAHYDROACRIDINE

1 g 5 g

10 g

16.1572.00

137.80[1684-40-8](Tacrine HCl; THA)HydrochlorideHydratePurity: ≥≥≥≥98%A potent centrally acting anticholinesterasefor therapy of memory deficits in patientswith Alzheimers’s disease. THA alsoselectively blocks potassium channels inthe central nervous system, which results inan increased release of acetylcholine and aprolongation of the action potential of thepresynaptic cholinergic neurons.C13H14N2 • HCl • H2O MW 252.7

150370 RT

5-AMINOVALERIC ACID 1 g 5 g

25 g

7.9027.9584.65

[627-95-2]CrystallineHydrochlorideA weak GABAB receptor antagonist.C5H11NO2 • HCl MW 153.6

153535 RT

AMIODARONE 250 mg1 g

21.5070.85[1951-25-3]

(2-Butyl-3-benzofuranyl)-[4-[2-(diethylamino)ethoxy]-3,5-diiodo-phenyl]-methanonehydrochloride)HydrochlorideC25H29I2NO3 • HCl MW 681.8

193612 RT

AMOXAPINE 100 mg500 mg

15.4563.95[14028-44-5]

(2-Chloro-11-(1-piperazinyl)-dibenz[b,f][1,4]oxazepine)Inhibitor of norepinephrine uptake inneurons.C17H16N3OCl MW 313.8

AMPASee: (±)-α-Amino-3-hydroxy-5-methylisoxazole-4-propionic acid

159014 RT

2-(p-AMYLCINNAMOYL)AMINO-4-CHLOROBENZOIC ACID

20 mg50 mg

100 mg

91.70212.10401.30(ONO-RS-082)

Purity: 98%Blocks PLA2 in human platelets whichinhibits epinephrine-stimulatedthromboxane production.Ref.: Banga, H.S., et.al., Proc. Natl. Acad.Sci. USA, 83, 9197 (1986).MW 371.9




159020 RT

N-(p-AMYLCINNAMOYL)-ANTHRANILIC ACID

50 mg100 mg250 mg

74.55131.90298.10[110683-10-8]

(ACA)Purity: 99%A close structural analog to ono-rs-082which is a less potent PLA2 inhibitor. Alsodemonstrates some leukotrieneantagonistic activity.Ref.: 1. Banga, H.S., et.al., Proc. Natl.Acad. Sci. USA, 83, 9197 (1986). 2. Nakai,H., et.al., J. Med. Chem., 21, 78 (1986).MW 337.4

159873 -20oC

(+)-ANATOXIN A 250 µg 133.00[64314-16-5](2-Acetyl-9-azabicyclo-[4.2.1]non-2-ene HCl)From Anabaena flos-aquaeHydrochloridePurity: 99%Potent neuronal nicotinic acetylcholinereceptor agonist. At high concentrations, itdesensitizes the receptor, blocksneuromuscular transmission, and blocksthe AChR ion channel.Ref.: 1. Thomas, P., et al., J. Neurochem.,60, 2308 (1993).2. Swanson, K.L., et al., Mol. Pharmacol.,29, 250 (1986).3. Kofuji, P., et al., J. Pharmacol. Exp. Ther.,252, 517 (1990).C10H15NO • HCl MW 201.5

158866 0oC

6-ANILINO-5,8-QUINOLINEDIONE 10 mg25 mg50 mg

93.50214.30413.00

[91300-60-6](LY 83583)Purity: 97%Inhibits nitric oxide induced activation ofsoluble guanylate cyclase. Also enhancescontractile responses of rat aorta and arteryto α-adrenoceptor agonists. Blocksleukotriene releases and acetylcholineinduced relaxation. Reducesplatelet-endothelial cell adhesion.Ref.: 1. Mulsch, A., et.al.,Naunyn-Schmeideberg’s Arch. Pharmacol.,340, 49 (1989). 2. Macleod, K.M., et.al.,Mol. Pharmacol., 32, 59 (1987). 3. Fleisch,J.H., et.al., J. Pharmacol. Exp. Ther., 229,681 (1984).C15H10N2O2 MW 250.3

193613 RT

ANIRACETAM 10 mg25 mg

30.0049.90[72432-10-1]

(Ro 13-5057;1-(4-Methoxybenzoyl)-2-pyrrolidinone)Reported to increase ion conductancethrough AMPA receptors, and also involvethe cholinergic system.Ref.: Toide, Arch. Int. Pharmacodyn., 298,25 (1989).C12H13NO3 MW 219.2

159881 -20oC

ANISOMYCIN 10 mg25 mg50 mg

29.0059.6090.00

[22862-76-6](2-[p-Methoxybenzyl]-3,4-pyrrolidinediol 3-acetate)From Streptomyces griseolusPurity: 97%Activates a restricted subset of kinasescurrently only identified by p54 and MAPkinase. Study aid for cytoplasmic signalsresulting in nuclear signaling and inductionof c-fos and c-jun.Ref.: 1. Kavdal, E., et al., Mol. Cell. Biol.,14, 1066 (1994).C14H19NO4 MW 265.3

691542 -20oC

ANNEXIN IMONOCLONAL ANTIBODY

50 µg 396.90

(anti-Lipocortin I; anti-Calpactin II;anti-Chromobindin 9; anti-p35)Anti-HumanClone: II-29Isotype: mouse IgG1Conc/Titer: 1:5,000Applications: Immunoblotting; ELISA;ImmunohistochemistryThis antibody reacts strongly with annexin Ifrom human or bovine tissue and does notcross-react with other annexins or otherproteins in a total lysate of humanfibroblasts as determined by Western Blot.It is packaged at a concentration of 1 mg/mlin 50% glycerol, 5 mM TRIS, pH 8.2, 25mM NaCl, and 1.5 mM sodium azide.Purity: ≥≥≥≥95%The hybridoma was elicited to annexin Ipurified from bovine lung.Ref.: 1. Creutz, C.E., et al., J. Biol. Chem.,262, 1860 (1987).2. Zokas, L. and Glenney, J.R., J. Cell.Biol., 105, 2111 (1987).

691552 -20oC

ANNEXIN IIMONOCLONAL ANTIBODY

50 µg 391.40

(Anti-Lipocortin II; anti-Calpactin I; anti-p36;anti-Chromobindin 8; anti-Protein I;anti-PAP IV)Anti-BovineClone: CPI-50Isotype: mouse IgG1Conc/Titer: 1:5,000Applications: Immunoblotting; ELISA;ImmunohistochemistryThis antibody reacts strongly with annexin IIfrom human or bovine tissues and does notcross-react with other annexins or otherproteins in a total lysate of humanfibroblasts as determined by Western Blot.It is packaged at a concentration of 1 mg/mlin 50% glycerol, 5 mM TRIS, pH8.2, 25 mMNaCl, and 1.5 mM sodium azide.Purity: ≥≥≥≥95%The hybridoma was elicited to annexin IIfrom bovine lung.

ANNEXIN II, Light ChainMONOCLONAL ANTIBODYAnti-HumanClone: LC148Isotype: mouse IgG1Conc/Titer: 1:5,000Applications: Immunoblotting; ELISA; ImmunohistochemistryThis is an 11 kDa light chain of annexin II, usually found tightlyassociated to annexin II (ICN Code No. 69-155-2). Annexin II is astructurally unique member of the annexins family because ofthis light chain. The other known annexins are monomeric, whileannexin II is a heterotetramer consisting of two subunits of eachtype.The antibody is packaged at a concentration of 1 mg/ml in 50%glycerol, 5 mMTRIS, ph8.2, 25 mM NaCl, and 1.5 mM sodiumazide.

691582 50 µg 275.60

691581 100 µg 452.00




691561 -20oC

ANNEXIN IVMONOCLONAL ANTIBODY

100 µg 282.90

(Anti-Calelectrin 32.5 kDa; anti-endoexin I;anti-Protein II; anti-Lipocortin IV;anti-Chromobindin IV; anti-PAP IV;anti-PP4-X; anti-Calcimedin 35β)Anti-HumanClone: CPIII-16Isotype: mouse IgG1Conc/Titer: 1:5,000Applications: Immunoblotting; ELISA;ImmunohistochemistryThis antibody reacts strongly with annexinIV from human or bovine tissues and doesnot cross-react with other annexins or otherproteins in a total lysate of humanfibroblasts as determined by Western Blot.It is packaged at a concentration of 1 mg/mlin 50% glycerol, 5 mM TRIS, pH8.2, 25 mMNaCl, and 1.5 mM sodium azide.Purity: ≥≥≥≥95%Ref.: 1. Creutz, C.E., et al., J. Biol. Chem.,262, 1860 (1987). 2. Crompton, M.R., etal., Cell, 55, 1 (1988).

ANNEXIN VIMONOCLONAL ANTIBODY(Anti-Calelectrin 67 kDa; anti-Lipocortin VI; anti-Protein III;anti-Chromobindin 20; anti-Calcimedin 67 kDa; anti-CalphobindinII; anti-p68; anti-p70)Anti-HumanClone: 73-5-4Isotype: mouse IgG1Conc/Titer: 1:5,000Applications: Immunoblotting; ELISA; ImmunohistochemistryThis antibody reacts strongly with annexin VI from human orbovine tissues and does not cross-react with other annexins orother proteins in a total lysate of human fibroblasts as determinedby Western Blot. It is packaged at a concentration of 1 mg/ml in50% glycerol, 5 mM TRIS, pH8.2, 25 mM NaCl, and 1.5 mMsodium azide.Purity: ≥≥≥≥95%The hybridoma was elicited to annexin VI purified from humanplacenta.

691572 50 µg 391.40

691571 100 µg 738.65

158867 -20-0oC

ANTHRYLMETHYL OKADAATE 10 µg25 µg50 µg

100 µg

54.45108.95194.95349.70

[157606-35-4]Purity: ≥≥≥≥98% (HPLC)A fluorescent derivative of okadaic acidused as a standard in okadaic acid analyis.Ref.: Lee, J.S., et.al., Agric. Biol. Chem.,51, 877 (1987).C59H78O13 MW 995.3

152328 0-5oC

ANTIBIOTIC A23187 1 mg 5 mg

10 mg

20.8552.5083.25

[52665-69-7](Calcium Ionophore A23187)Free AcidWhite crystalline solid.Antibiotic A23187 is an antibiotic whichdemonstrates weak in vitro activity againstgram-positive bacteria and fungi. It also hasthe ability to form stable complexes withdivalent cations, increasing their ability tocross biological membranes, thus givingA23187 properties as an ionophore. Its U.V.and fluorescence spectral properties allowthis calcium ionophore to be useful as acytoplasmic free calcium ion probe. A23187does exhibit toxicity and is a potentialhealth hazard, so caution should be usedwhen handling, in accordance with normalprocedures for handling toxic compounds.C29H37N3O6 MW 523.6

152329 0-5oC

ANTIBIOTIC A23187 1 mg5 mg

10 mg

17.1544.2080.40

Mixed Calcium-Magnesium SaltC29H37N3O6 MW 523.6 (free acid)

152843 -20-0oC

ANTIPAIN 1 mg5 mg

25 mg

13.7545.00

160.00[37691-11-5]([(S)-1-Carboxy-2-phenylethyl]-carbamoyl-Arg-Val-Arg-al)Source/Species: MicrobialInhibitor for trypsin, papain, and cathepsinsA and B.Ref: 1. Suda, H., et al., J. Antibiot., 25, 263(1972); 2. Umezawa, H., et al., J. Antibiot.,25, 267 (1972); 3. Ikezawa, H., et al., J.Antibiot., 25, 738 (1972).C27H44N10O6 MW 604.7

198585 -20-0oC

ANTIPAIN 1 mg5 mg

25 mg100 mg

8.5019.0047.50

150.00

[37682-72-7]([(S)-1-Carboxy-2-phenylethyl]-carbamoyl-Arg-Val-Arg-al)HydrochlorideSource/Species: MicrobialInhibitor for trypsin, papain, and cathepsinsA and B.Ref: 1. Suda, H., et al., J. Antibiot., 25, 263(1972); 2. Umezawa, H., et al., J. Antibiot.,25, 267 (1972); 3. Ikezawa, H., et al., J.Antibiot., 25, 738 (1972).C27H44N10O6 • HCl MW 641.2

190153 -20oC

APAMIN 0.5 mg1 mg

75.30135.65[24345-16-2]

Bee VenomResearch GradeCys-Asn-Cys-Lys-Ala-Pro-Glu-Thr-Ala-Leu-Cys-Ala-Arg-Cys-Gln-Gln-His-NH2. S-Sbridge between Cys1-Cys11 and Cys3-Cys17.Ref.: Habermann, E., (1972), Science, 177,314-22; Gauldie, J., et. al., (1976), Eur. J.Biochem., 61, 369-76.MW 2027.3

159883 -20oC

APHIDICOLIN 1 mg5 mg

10 mg

56.45223.65403.05

[38966-21-1]From Nigrospora sphaericaPurity: 98%Inhibits the early S-phase of the cell cycle.DNA polymerase α and δ reversibleinhibitor.Ref.: 1. Levenson, V. and Hamlin, J.L.,Nucleic Acids Res., 21, 3997 (1994).2. O’Dwyer, P.J., et al., Cancer Res., 54,724 (1994).C20H34O4 MW 338.5

153635 0-5oC

R(-)-APOCODEINE 25 mg50 mg

100 mg

45.5074.40

131.00[641-36-1](R(-)-10-methoxy-11-hydroxyaporphine)HydrochlorideDopamine receptor agonist.Off-white, photosensitive solid; mp260-264°C. Store tightly sealed at 4 °C,away from light. Soluble in water; soluble inalcohol.C18H19NO2 • HCl MW 317.7

153634 0-5oC

R(-)-APOMORPHINE 25 mg50 mg

100 mg

11.5517.3528.85

[314-19-2]((-)-APO HCl;R(-)-10,11-dihydroxyaporphine)HydrochlorideDopamine receptor agonist.C17H17NO2 • HCl MW 303.7

153633 -20-0oC

S(+)-APOMORPHINE 1 mg2 mg5 mg

67.60112.35246.55

[41035-30-7](S(+)-10,11-dihydroxyaporphine)HydrochlorideDopamine receptor antagonist (inactive asan agonist).C17H17NO2 • HCl MW 303.7




190382 0-5oC

APROTININ 10 mg50 mg

50.65139.05[9087-70-1]

From Bovine LungAnalytical GradeLyophilized white powderActivity: Approx. 6000Kallikrein-inhibitor-units per mg (KIU).Unit Definition: One KIU (KallikreinInactivating Unit) is identical to the quantityof protease inhibitor that has the ability toinhibit 2 Kallikrein units by 50% underoptimal conditions.Ref.: Kunitz, M. and Northrup, J.H., Gen.Physiol., 19, 991 (1966)MW ∼ 6500

191158 0-5oC

APROTININ 1 mg5 mg

10 mg25 mg

100 mg250 mg

9.1527.7039.8090.00

277.85610.50

[9087-70-1]From Bovine LungLyophilized white powderActivity: 3-4 Inhibitor units/mg of dryweight. One Inhibitor unit = 1500 KIU.

194559 0-5oC

APROTININ 10 mg25 mg

100 mg250 mg

57.30130.70403.10958.60

[9087-70-1]Cell Culture ReagentFrom Bovine LungLyophilized white powderActivity: 3-4 Inhibitor units/mg of dryweight. One Inhibitor unit = 1500 KIU.

150384 0oC

ARACHIDONIC ACID 10 mg50 mg

100 mg500 mg

1 g

13.3036.6058.80

112.00204.00

[506-32-1]Purity: ≥≥≥≥98%Clear, colorless liquid which may develop ayellowish cast.Activates protein kinase CC20H32O2 MW 304.5

194625 0oC

ARACHIDONIC ACID 10 mg50 mg

100 mg500 mg

17.9050.1082.35

200.30

[506-32-1]Cell Culture ReagentPurity: 99%Clear, colorless liquid which may develop ayellowish cast.C20H32O2 MW 304.5

159884 -20oC

ARACHIDONIC ACIDTRIFLUOROMETHYLKETONE

5 mg10 mg25 mg

63.05105.50235.05[149301-79-1]

(AACOCF3)Purity: 98%Arachidonic acid analog which selectivelyinhibits human cytosolic phospholipase A2.Ref.: 1. Street, J.P., et al., Biochemistry, 32,5935 (1993); 2. Bartoli, F., et al., J. Biol.Chem., 269, 15625 (1994).C21H31OF3 MW 356.5

154794 RT

ARCAINE 50 mg250 mg

48.50189.65[36587-93-6]

(1,4-Diguanidinobutane)Sulfate SaltCrystallineNMDA antagonistC6H16N6 MW 270.3

100728 RT

ARECOLINE 5 g 10 g 50 g

18.0031.00

132.00[300-08-3]HydrobromideCrystallineIncreases levels of acetylcholine in thebrain.C8H13NO2 • HBr MW 236.1

191238 -20-0oC

D-ARGININE 1 g 5 g

28.45103.60[157-06-2]

Free BaseC6H14N4O2 MW 174.20

100736 RT

L-ARGININE 100 g 500 g

1 kg

17.4555.9093.15

[74-79-3]Free BaseCrystallinePurity: 99%C6H14N4O2 MW 174.2

194626 RT

L-ARGININE 25 g 100 g 500 g

7.9021.3069.60

[74-79-3]Cell Culture ReagentFree BasePurity: 99%C6H14N4O2 MW 174.2

159019 RT

ARISTOLOCHIC ACID 50 mg100 mg250 mg

40.0075.40

178.50[313-67-7]From AristolochiaceaePurity: 97%1:1 mixture of aristolochic acids I and II. Aphenanthrene carboxylic acid derivativewhich irreversibly blocks phospholipase A2from various sources.Ref.: 1. Vishwanath, B.S., et.al., Toxicon,25, 501, 929, 939 (1987). 2. Vishwanath,B.S., et.al., Inflammation, 12, 549 (1988). 3.Rosenthal, M.D., et.al., Biochem. Biophys.Acta, 1001, 3 (1989).MW 341.3

159018 RT

ARISTOLOCHIC ACID 50 mg100 mg250 mg

35.0065.00

142.50Sodium SaltPurity: 97%1:1 mixture of aristolochic acid I andaristolochic acid II.MW 363.2

159886 RT

ASTEMIZOLE 100 mg500 mg

1 g

18.0070.00

124.00[68844-77-9](1-[(4-Fluorophenyl)methyl]-N-[1-[2-(4-methoxyphenyl)ethyl]-4-piperidinyl]-1H-benzimidazol-2-amine)Purity: 99%Selective antagonist for the histamine H1receptor.Ref.: 1. Laduron, P.M., et al., Mol.Pharmacol., 21, 294 (1982).2. Richards, D.M., et al., Drugs, 28, 38(1984).C28H31FN4O MW 458.6

153961 RT

AURANOFIN 100 mg250 mg500 mg

1 g

49.20102.40170.80284.55

(S-Triethylphosphinegold(I)-2,3,4,6-tetra-O-acetyl-1-thio-β-D-glucopyranoside)MW 678.27

158869 0-5oC

AUSTRALINE 1 mg 63.05([(1R, 2R, 3R, 7S,7R)-3-hydroxymethyl-1,2,7-trihydroxypyrrolizidine])Purity: 99%Inhibitor of amyloglucosidase andglucosidase I (more selective overglucosidase II).Ref.: Molyneux, R.J., et.al., J. Nat. Prod.,51, 1198 (1988)MW 189

193614 -20oC

AUTOCAMTIDE-2 500 µg1 mg

55.0093.60Lys-Lys-Ala-Leu-Arg-Arg-Gln-Glu-Thr-Val-As

p-Ala-LeuPurity: >97%Very selective CAMKII substrate whichexhibits no activity towards PKA.Ref.: Hanson, P.I., et al., Neuron, 3, 59(1989).MW 1526.9

154260 -20oC

(±±±±)-13-AZAPROSTANOIC ACID 1 mg 57.00Purity: 98%Crystalline13-APA antagonizes the actions ofthromboxane A2.Binding to the platelet TXA2/PGH2 receptoris stereospecific and reversible.MW 311.5

191364 0oC

AZATHIOPRINE 100 mg250 mg

1 g 5 g

9.0014.3544.00

171.30

[446-86-6](6-[(1-Methyl-4-nitroimidazol-5-yl)-thio] purine)CrystallineImmunosuppresive and cytostatic agent.C9H7N7O2S MW 277.3




153632 0-5oC

(R)-2-AZIDO-N6-p-HYDROXY-PHENYLISOPROPYLADENOSINE

2 mg5 mg

10 mg

36.1565.10

115.70[98897-11-1][(R)AHPIA]Photoaffinity ligand for the A1 Adenosinereceptor.C19H22N8O5 MW 442.4

158870 RT

7-AZIDOKETANSERIN 25 mg50 mg

321.05584.75(R 63836)

Purity: 99%Photoaffinity probe for 5-HT and histaminereceptors.Ref.: 1. Wouters, W., et.al., FEBS, 182, 291(1985). 2. Wouters, W., et.al., J. Biol.Chem., 260, 8423 (1985).MW 436.4

-B-

159793 0-5oC

BACCATINE III 1 mg5 mg

10 mg

21.9573.15

135.00[27548-93-2]Starting material for taxol derivatives.Ref.: Wheeler, N.C., J. Natl. Prod., 55, 432(1992).C31H38O11 MW 586.6

159794 0-5oC

BACCATINE III-7,13-DIACETATE 5 mg 166.95Distinguishes between mammalian andamoebic microtubules.Ref.: Lataste, H., et al., Proc. Natl. Acad.Sci. USA, 81, 4090 (1984).C35H42O13 MW 670.7

153629 RT

(±±±±)-BACLOFEN 100 mg500 mg

11.0016.00[1134-47-0]

((±)-β-(Aminoethyl)-4-chlorobenzenepropanoic acid)White solid; mp 192-193°C. Store tightlysealed. Soluble in water, dilute acid andbase.C10H12NO2Cl MW 213.7

16030 0-5oC

(-)-BACLOFEN, [Butyl-4-14C(U)] 50 µCi 1308.55Sp. Act. 50-60 mCi/mmol1.85-2.22 GBq/mmolEthanol:water (7:3).Please call for delivery information.p-ClC6H5CH(CH2CO2H)CH2NH2MW 213.67

26024 0-5oC

(-)-BACLOFEN, [Butyl-4-3H] 250 µCi 787.10Sp. Act. 30-60 Ci/mmol1.11-2.22 TBq/mmolEthanol:water (7:3).Please call for delivery information.p-ClC6H5CH(CH2CO2H)CH2NH2

159555 0oC

BAFILOMYCIN A1 10 µg25 µg

88.90183.45[88899-55-2]

From Streptomyces griseusPurity: ∼∼∼∼90%ATPase inhibitor.C35H58O9 MW 622.8

159067 0oC

BAICALEIN 5 mg10 mg50 mg

33.2060.70

255.00[491-67-8](5,6,7-Trihydroxyflavone)Purity: 98%Specifically inhibits 12-lipoxygenase andleukotriene biosynthesis.Ref.: Kimura, Y., et.al., Biochim. Biophys.Acta, 922, 278 (1987).C15H10O5 MW 270.2

153628 0-5oC

(±±±±)-BAY K 8644 1 mg2 mg5 mg

30.0055.00

116.50[98791-67-4](1,4-Dihydro-2,6-dimethyl-5-nitro-4-[2-(trifluoromethyl)-phenyl]-3-pyridine-carboxylic acid methyl ester)C16H15F3N2O4 MW 356.3

154261 -20oC

BENSERAZIDE 100 mg500 mg

53.00238.00[14919-77-8]

HydrochlorideTan solidC10H15N3O5 • HCl MW 293.7

159795 RT

BENZAMIL 1 mg5 mg

25 mg

6.9513.0056.50

[2898-76-2](Benzylamiloride hydrochloride)HydrochloridePotent Na+-channel blocker.C13H14N7OCl • HCl MW 356.2

150433 0oC

(±±±±)-BENZETIMIDE 5 mg10 mg25 mg

11.7548.1049.90

(3-phenyl-3-[1-(phenylmethyl)-4-piperidinyl]-2, 6- piperidinedione; R4929)HydrochlorideRef.: (1) Resolution of isomers andpharmacology: van Wijngaarden, Life Sci.,8, 517 (1969); (2) van Wijngaarden,Soudijn, Life Sci., 7, 225 (1968).

159724 RT

BENZOQUINONIUM DIBROMIDE 1 mg5 mg

10 mg

21.2084.85

155.90[311-09-1]Nicotinic antagonist that blocks ganglion.C34H50N4O2Br2 MW 706.6

151443 RT

BENZOTRIPT 100 mg500 mg

122.50340.05[39544-74-6]

(N-[4-chlorobenzoyl]-L-tryptophan)Selective cholecystokinin antagonist;gastrin receptor antagonist.Ref.: Magous, et al., Regul. Pept., 7, 233(1983).C18H15N2O3Cl MW 342.8

153626 RT

BENZTROPINE MESYLATE 25 mg100 mg

10.1028.85[132-17-2]

(3-(Diphenylmethoxy)-8-methyl-8-azabicyclo[3.2.1]octane methane sulfonate)CrystallineMuscarinic receptor antagonist.C22H29NO4S MW 403.5

150449 0oC

N6-BENZYLADENOSINE 100 mg250 mg

9.9518.00[4294-16-0]

(6-Benzylaminopurine riboside)CrystallineAn A1 Adenosine receptor agonist.C17H19N5O4 MW 357.4

N-BENZYL-3,4-DIHYDROXY-αααα-CYANOCINNAMIDESee: Tyrphostin B42

193615 0-5oC

N6-BENZYL-5′′′′-N-ETHYLCARBOXAMIDOADENOSINE

1 mg5 mg

22.0582.70

(N6-Benzyl-NECA)An A3 Adenosine receptor agonist.Ref.: Gallo-Rodriquez, et al., J. Med.Chem., 37, 636 (1994).C19H22N6O4 MW 398.4

1-BENZYL-1-METHYL-4-CYCLOPENTYLMETHOXY-CARBONYLPIPERIDINIUM BROMIDESee: BMCP

104861 RT

BENZYLOXYAMINE 1 g 5 g

25 g

12.6530.00

120.00[2687-43-6](O-Benzylhydroxylamine)HydrochlorideCrystallineDopamine β-hydroxylase inhibitor.Derivatizing reagent for GLC analysis ofketosteroids.C7H9NO • HCl MW 159.6

159893 RT

BENZYLPHOSPHONIC ACID 50 mg100 mg500 mg

17.2028.6591.70

[6881-57-8]Purity: 98%Structural mimic of phosphotyrosine.Inhibits bovine heart tyrosine-proteinphosphatase. Not cell permeable.Ref.: Zhand, Z.-Y. and Van Etten, R.L.,Arch. Biochem. Biophys., 282, 39 (1990).MW 172.1




159894 -20oC

BENZYLPHOSPHONIC ACID-(AM)2 10 mg 103.20(Benzylphosphonic acid bis-acetoxymethylester)Purity: 98%Cell permeable tyrosine phosphataseinhibitor.MW 316.3

153627 RT

BEPRIDIL 15 mg25 mg50 mg

40.0053.0094.00

[74764-40-2]HydrochlorideA non-selective calcium channel blocker.C24H34N2O • HCl MW 403

159895 -20oC

E6 BERBAMINE 5 mg10 mg

80.25137.60Purity: 98%

A selective and potent cell permeableantagonist of calmodulin.Ref.: Hu, Z.-Y., et al., Biochem. Pharmacol.,44, 1543 (1992).MW 757.8

195857 RT

BERBERINE 1 g 5 g

25 g

10.1520.0080.00

[633-65-8](Natural Yellow 18; C.I. 75160)ChlorideApoptosis Inhibitor.C20H18NO4Cl MW 371.8

152844 -20-0oC

BESTATIN 1 mg5 mg

10 mg25 mg

16.9550.1583.60

156.50

[58970-76-6]([(2S,3R)-3-Amino-2-hydroxy-4-phenylbutanoyl]-Leu)Free AcidInhibitor for aminopeptidase B and leucineaminopeptidase.Ref: Umezawa, H., et al., J. Antibiot., 29,97 (1976).C16H24N2O4 MW 308.4

193616 RT

BETAXOLOL 5 mg25 mg

74.95303.20[63659-19-8]

HydrochlorideA selective β1-adrenoceptor antagonist.C18H29NO3 • HCl MW 343.9

198588 RT

BETAXOLOL 5 mg25 mg

74.95303.20[63659-19-8]

HydrochlorideMonohydrateA selective β1-adrenoceptor antagonist.C18H29NO3 • HCl • H2O MW 352.9

190160 0-5oC

BETHANECHOL CHLORIDE 5 g 25 g

100 g

19.8562.00

201.35[590-63-6](Carbamyl-β-methylcholine chloride)Cholinergic receptor agonistC7H17N2O2Cl MW 196.7

195859 0-5oC

BETULINIC ACID 1 mg5 mg

39.90152.25[472-15-1]

(3β-Hydroxy-20(29)-lupaene-28-oic acid)Purity: ≥≥≥≥97%Selectively inhibits human melanoma in cellculture and in animal models anddemonstrates antitumor properties byinducing apoptosis. Possess anti-HIVproperties.C30H48O3 MW 456.7

190789 0oC

(+)-BICUCULLINE 100 mg250 mg500 mg

1 g

29.1057.40

109.45166.40

[485-49-4]CrystallineGABA blocker.C20H17NO6 MW 367.4

158872 0-5oC

(-)-BICUCULLINE METHOBROMIDE 25 mg100 mg250 mg

25.2575.00

179.50[73604-30-5]Purity: 98%GABAA antagonist.Ref.: Hill, D.R. and Bowery, N.G., Nature,290, 149 (1981)C21H20NO6 • Br MW 462.3

159726 0-5oC

(-)-BICUCULLINE METHOCHLORIDE 5 mg10 mg25 mg

20.0031.0065.50

[53552-05-9]A water soluble GABA antagonist.C21H20NO6Cl MW 417.8

16031 0-5oC

(-)-BICUCULLINEMETHYLCHLORIDE, [Methyl-14C]

50 µCi 969.00

Sp. Act. 50-60 mCi/mmol1.85-2.22 GBq/mmolEthanol under nitrogenShipped in dry ice.Please call for delivery information.MW 417.8

26025 0-5oC

(-)-BICUCULLINEMETHYLCHLORIDE, [Methyl-3H]

250 µCi1 mCi

726.451939.20

Sp. Act. 60-90 Ci/mmol2.22-3.33 TBq/mmolEthanol under nitrogenShipped in dry ice.Please call for delivery information.

158873 -20-0oC

BIOALLETHRIN 25 mg50 mg

36.4069.20[22431-63-6]

(D-trans-Allethrin)Mixture of isomersBioallethrin is a Type I pyrethrin and itmimics Type II pyrethrins on the inhibition ofcalcineurin (protein phosphatase 2B). It is amore potent inhibitor of calcineurin thanallethrin and other Type I pyrethrins.C19H26O3 MW 302.42

194137 0-5oC

BISINDOLYLMALEIMIDE I 250 µg1 mg

28.6085.00[133052-90-1]

(GF109203X)Purity: 98%HydrochlorideProtein Kinase C inhibitor.Ref.: Davis, P.D., et al., J. Med. Chem., 35,994 (1992).C25H24N4O2 • HCl MW 449.0

194138 0-5oC

BISINDOLYLMALEIMIDE I 250 µg1 mg

66.15232.00(GF109203X)

Purity: 98%Highly selective Protein Kinase C inhibitor.Ref.: Toullec, D., et al., J. Biol. Chem., 266,15771 (1991).C25H24N4O2 MW 411.5

194139 0-5oC

BISINDOLYLMALEIMIDE II 250 µg1 mg

82.70216.10(2-(1-[2-(1-Methylpyrrolidino)ethyl]-1H-indol-3

-yl-3-(1H-indol-3-yl)maleimide)Purity: 95%Potently and selectively inhibits ProteinKinase C.Ref.: Toullec, D., et al., J. Biol. Chem., 266,15771 (1991).C27H26N4O2 MW 438.5

196040 RT

BLANKOPHOR 10 ml25 ml

100 ml

23.1051.00

181.00[16470-24-9](Benzenesulfonic acid,2,2′-(1,2-ethenediyl)bis[5-[[4-[bis(2-hydroxyethyl)amino]-6-[(4-sulfophenyl)amino]-1,3,5-triazin-2-yl]amino]-tetrasodium salt)Purity: ≥≥≥≥90%A highly selective fluorescent probe ofβ-amyloid and amyloid plaque core protein(APCP). It does not fade during prolongedexposure to UV blue exciting light.Ref.: Roher, A., et al., Proceed. Nat. Acad.of Sci., 83, 2662-2666 (1986).

190307 -20-0oC

BOMBESIN 1 mg5 mg

61.00266.00[31362-50-2]

(pyroGlu-Gln-Arg-Leu-Gly-Asn-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH2)A tetradecapeptide that has biologicalactivities in the central nervous system andgastrointestinal tract; also hasthermoregulatory effects.Ref.: 1. Bertaccini, G., et al., Br. J.Pharmac., 52, 219 (1974).2. Erspamer, V., et al., Br. J. Pharmac., 52,227 (1974).3. Rivier, J.E. and Brown, M.R.,Biochemistry, 17, 1776 (1978).C71H110N24O18S MW 1619.9




154608 0oC

BOROGLYCINE 5 mg15 mg

198.50407.35(Ammonia-carboxyborane)

Purity: >97%Potent hypocholesterolemic agent.β-Hydroxy-β-methylglutaryl-CoA reductaseinhibitor.Ref.: I.H. Hall, M.K. Das, F. Harchelroad,Jr., P. Wisian-Neilson, A.T. McPhail and B.F.Spielvogel, J. Pharm. Sci. 70, 339 (1981).BCH6NO2 MW 74.88

154609 0oC

BOROSARCOSINE 5 mg15 mg

198.50407.35(Boromethylglycine,

methylamine-carboxyborane)Purity: >97%Dihydrofolate reductase inhibitor, DNApolymerase inhibitor.Ref.: I.H. Hall, C.J. Gilbert, A.T. McPhail,K.W. Morse, K. Hassett and B.F. Spielvogel,J. Pharm. Sci., 74, 755 (1985).BC2H8NO2 MW 88.9

193950 -20oC

BRAIN DERIVED NEUROTROPHICFACTOR

5 µg 180.50

(BDNF)Human, RecombinantPurity: ≥≥≥≥95%Produced in E. coliA neurotrophin which promotes sensoryganglions and motor neurons survival anddifferentitation.MW ∼28 kDa

159027 -20oC

BREFELDIN A 5 mg25 mg

67.80268.15[20350-15-6]

(γ,4-Dihydroxy-2-[6-hydroxy-1-heptenyl]-4-cyclopentanecrotonic acid λ-lactone; BFA)Purity: 98%Blocks binding of the cytosolic coat proteinβ-COP and ARF to Golgi membranesmediated by protein G. Also blocks proteintransportation into post-Golgicompartments.Ref.: 1. Donaldson, J.G., et.al., Science,254, 1197 (1991).2. Donaldson, J.G., et.al., J. Cell. Biol., 112,579 (1991).3. Orci, L., et.al. Cell, 64, 1183 (1991).4. Lippincott-Schwartz, J., et.al., ibid., 60,821 (1990).C16H24O4 MW 280.4

26026 0-5oC

BREFELDIN A, [3H] 250 µCi EnquireSp. Act. 15-30 Ci/mmol0.555-1.11 TBq/mmolEthanolPlease call for delivery information.MW 280.37

195711 -20-0oC

BREVETOXIN PbTx-1 100 µg 382.00[98112-41-5]From Ptychodiscus brevisPurity: ≥≥≥≥95%Voltage-dependent sodium channelactivator.CAUTION! HIGHLY TOXIC!MW 866.6

158876 -20-0oC

BREVETOXIN PbTx-9 10 µg25 µg50 µg

116.00290.00504.00

From Ptychodiscus brevisPurity: ≥≥≥≥95%Cyclic polyether which causes contractileparalysis in animal models. Do not useDMSO as a solvent.MW 898.6

153759 0oC

BROMOACETYL ALPRENOLOLMENTHANE

15 mg25 mg50 mg

40.5572.25

137.45[76298-90-3]A β-adrenergic antagonistC24H37BrN2O3 MW 481.5

158877 -20-0oC

8-BROMOADENOSINE-3′′′′,5′′′′-cyclic-MONOPHOSPHATE

10 mg25 mg50 mg

100 mg

40.0075.00

145.00276.00

[76939-46-3]Sodium SaltPurity: 98%cAMP analog more resistant tophosphodiesterases than cAMP. ActivatescAMP-dependent protein kinase.Ref.: 1. Meyer, R.B. and Miller, J.P., LifeSci., 14, 1019 (1974).2. Hei, Y.-J., et.al., Mol. Pharmacol., 39,223 (1991).3. Sandberg, M., et.al., Biochem. J., 279,521 (1991).C10H10BrN5O6PNa MW 430.1

159729 -20-0oC

BROMOBIMANE 5 mg25 mg

21.0080.50[71418-44-5]

Substrate for glutathionetransferase andfluorescent labeling reagent for Thiols.C10H11N2O2Br MW 271.1

158878 0oC

N-[2-(p-BROMOCINNAMYL-AMINO)ETHYL]-5-ISO-QUINOLINESULFONAMIDE

5 mg10 mg25 mg

68.75131.90313.00

[127243-85-0](H-89)DihydrochloridePurity: 99%Specific and potent inhibitor of PKA.Ref.: Nishizuka, Y., Science, 233, 305(1986).MW 519.2

BROMOCONDURITOLSee: 6-Bromo-4-cyclohexene-1,2,3-triol

153758 0-5oC

(+)-BROMOCRIPTINE MESYLATE 10 mg25 mg

100 mg

19.1027.1072.50

[22260-51-1](2-Bromo-12′-hydroxy-2′-(1-methylethyl)-5′-(2-methyl-propyl)ergotaman-3′,6′,18-trionemethanesulfonate)Methanesulfonate SaltC32H40N5O5Br • CH4SO3 MW 750.7

158879 0-5oC

6-BROMO-4-CYCLOHEXENE-1,2,3-TRIOL

1 mg5 mg

11.0048.70

[42014-74-4](6-Bromo-3,4,5-trihydroxycyclohex-1-ene;Bromoconduritol)Purity: 99%Mixed isomersInhibitor of mammalian α-glucosidase IIover α-glucosidase I.Ref.: Datema, R., et.al., Proc. Natl. Acad.Sci. USA, 79, 6787 (1982).C6H9BrO3 MW 209

158880 -20-0oC

8-BROMOGUANOSINE-3′′′′,5′′′′-cyclic-MONOPHOSPHATE

5 mg10 mg25 mg

21.9037.8087.00[51116-01-9]

(8-Bromo-cGMP)Sodium SaltPurity: 96%Activates cGMP-dependent protein kinase.Inhibitor of thrombin induced arachidonicacid release in human platelets.Ref.: 1. Meyer, R.B. and Miller, J.P., LifeSci., 14, 1019 (1974). 2. Francis, S.G.,et.al., ibid., 34, 506 (1988). 3. Schultz, K.D.,et.al., Naunyn-Schmiedeberg’s Arch.Pharmacol., 306, 1 (1979). 4. Sane, D.C.,et.al., Biochem. Biophys. Res. Commun.,165, 708 (1989).C10H10BrN5O7PNa MW 446.1

193617 RT

(RS)-4-BROMOHOMOIBOTENIC ACID 1 mg5 mg

10 mg

24.2597.00

187.40[71366-32-0]A potent AMPA receptor agonist. UnlikeAMPA, it also shows affinity forCaCl2-dependent L-glutamate binding sites.Ref.: Chung, et al., J. Neurochem., 63, 133(1994).C6H7N2O4Br MW 251.0




193620 -20oC

3-BROMO-7-NITROINDAZOLE 10 mg25 mg

52.2576.00[74209-34-0]

Purity: ≥≥≥≥97%More potent inhibitor of nitric oxidesynthase (NOS) than 7-nitroindazole.C7H4N3O2Br MW 242.0

152407 0-5oC

(+)-p-BROMOTETRAMISOLE 25 mg100 mg

61.00224.00[71461-24-0]

((+)-6(4-bromophenyl)-2,3,5,6-tetrahydroimidazo[2,1-b]thiazole ethanedioate)Oxalate SaltPurity: 99%An alkaline phosphate inhibitor. Shown toexhibit slightly less potent inhibition than(-)-p-Bromotetramisole make the dextro (+)form ideal for internal control applications.C11H11BrN2S • C2H2O4 MW 373.2

152408 0-5oC

(-)-p-BROMOTETRAMISOLE 25 mg100 mg

71.30177.95[62284-79-1]

((-)-6(4-bromophenyl)-2,3,5,6-tetrahydroimidazo[2,1-b]thiazole ethanedioate; R 30402)Oxalate SaltPurity: 99%A potent alkaline phosphate inhibitor.(-)-p-Bromotetramisole has been shown tofunction more effectively in the quantitativedetermination of intestinal and placentalisoenzymes of alkaline phosphatase inhuman serum than the more commonlyused L-phenylalanine.C11H11BrN2S • C2H2O4 MW 373.2

159558 0oC

BRYOSTATIN 1 10 µg 156.00[83314-1-6]Activates Protein Kinase C.C47H66O16 MW 887.0

159559 0oC

BRYOSTATIN 2 25 µg 395.00[87745-28-6]Binds to and activates Protein Kinase C.

154475 0-5oC

BUCCALIN 1 mg5 mg

72.25289.20[116844-51-0]

(Modulatory Neuropeptide)H2N-Gly-Met-Asp-Ser-Leu-Ala-Phe-Ser-Gly-Gly-Leu-NH2Ref.: Cropper, E.C., et al., (1988), PNAS,85, 6177MW 1053.3

153761 RT

(+)-BULBOCAPNINE 05 mg10 mg

25.0048.00[632-47-3]

HydrochlorideDopamine antagonistC19H19NO4 • HCl MW 361.8

153762 RT

(+)-BULBOCAPNINE 10 mg15 mg25 mg

63.0089.25

144.60[298-45-3]Dopamine antagonistC19H19NO4 MW 325.3

154263 0-5oC

BUMETANIDE 250 mg1 g 5 g

16.2046.30

194.75[28395-03-1]White micronized solidPurity: 99%An inhibitor of sodium and potassiumcotransport.C17H20N2O5S MW 364

193621 -20oC

αααα-BUNGAROTOXIN 500 µg1 mg

62.10116.50[11032-79-4]

A neurotoxin that irreversibly binds topost-synaptic cholinergic receptors,producing neuromuscular blockade andskeletal muscle paralysis. Useful as aprobe for acetylcholine receptors.Isolated from Bungarus multicinctus snakevenom.Ref.: Mebs, et al., Biochem. Biophys. Res.Comm., 44, 711 (1971).MW 7907.2

153760 RT

BUPROPION 15 mg25 mg50 mg

27.1038.1070.75

[31677-93-7]((±)-1-(3-Chlorophenyl)-2-[(1,1-dimethylethyl)amino]-1-propanone hydrochloride)HydrochlorideDopamine uptake inhibitorC13H18NOCl • HCl MW 276.2

154905 0-5oC

BUSPIRONE 1 g 5 g

35.00154.00[33386-08-2]

(N-[4-(4-[2-Pyrimidinyl]-1-piperazinyl)butyl]-8-azaspiro[4, 5]decane-7, 9-dione)HydrochlorideA 5-HT1A Serotonin receptor agonistC21H31N5O2 • HCl MW 422

153623 RT

(+)-BUTACLAMOL 5 mg25 mg50 mg

34.40150.00285.00

HydrochlorideD1/D2 Dopamine antagonistC25H31NO • HCl MW 398

158881 RT

4-(3-BUTOXY-4-METHOXYBENZYL)-2-IMIDAZOLIDINONE

100 mg500 mg

43.00172.35

[29925-17-5](Ro 201724)Purity: 99%Strong inhibitor of cAMP specificphosphodiesterase. Use in cell culture hasbeen demonstrated with a blood brainbarrier model.Ref.: 1. Sheppard, H., et.al., Adv. CyclicNucleotide Res., 1, 103 (1972). 2. Reeves,M.L., et.al., Biochem. J., 241, 535 (1987). 3.Katano, y. and Endoh, M., Biochem.Biophys. Res. Commun., 167, 123 (1990).4. Rubin, L.L., et.al., J. Cell Biol., 115, 1725(1991).C15H22N2O3 MW 278.4

153550 0-5oC

t-BUTYL-BICYCLO[2.2.2]PHOSPHOROTHIONATE

1 mg2 mg

108.45185.00

[70636-86-1](TBPS)A GABAA receptor antagonist, and chloridechannel blockerC8H15O3PS MW 222.4

193743 RT

3-tert-BUTYL-5-METHOXY-1,2-QUINONE

10 mg25 mg50 mg

29.0065.00

121.00[2940-63-8]Cytotoxic agent to P388 and KB cells.Ref.: Lam, L.K.T., J. Pharm. Sci., 77, 393-5(1988).C11H14O3 MW 194.3

195601 0-5oC

BUTYROLACTONE I 1 mg5 mg

126.80527.00(α-oxo-β(p-Hydroxyphenyl)-γ-(p-hydroxy-m-3

,3-dimethylallylbenzyl)-γ-methoxycarbonyl-γ-butrylactone)Purity: >99%A selective inhibitor of cdk2 and cdc2kinase.DO NOT STERILIZE.C24H24O7 MW 424

-C-

195680 -20oC

C3 EXOENZYME 10 µg 262.50From Clostridium botulinumLyophilizedUseful for Rho and related protein functionanalysis including lymphocyte-mediatedcytotoxicity, cell motility andthrombin-induced platelet aggregation. Itselectively ADP-ribosylates G proteins oflow molecular weight.

193745 0-5oC

CAFESTOL 10 mg25 mg50 mg

100 mg

30.8563.95

111.35192.95

[469-83-0]From Coffee BeansA natural extract which induces glutathioneS-transferase.Ref.: Lam, L.K.T., et al., Cancer Res., 42,1193-98 (1982).C20H28O3 MW 316.4




193747 0-5oC

CAFESTOL PALMITATE 10 mg25 mg50 mg

100 mg

32.0070.00

135.00250.00

[81760-46-5]A naturally occurring ester present in greencoffee beans.Ref.: Lam, L.K.T., et al., Cancer Res., 42,1193-98 (1982).C36H58O4 MW 554.4

104797 RT

CAFFEIC ACID 1 g 5 g

25 g

7.4018.0062.15

[331-39-5](3,4-Dihydroxycinnamic acid)Yellowish-brown crystalsC9H8O4 MW 180.2

195860 -20oC

CAFFEIC ACID PHENETHYL ESTER 1 mg5 mg

10.5040.85[104594-70-9]

(CAPE)Purity: ≥≥≥≥97%Active component of propolis fromhoneybee hives. Possesses anti-viral,anti-inflammatory and immunomodularyproperties. Inhibits growth of several typesof transformed cells and induces apoptosisin cloned rat embryo fibroblast (CREF) cells.C17H16O4 MW 284.3

101194 RT

CAFFEINE 100 g 250 g 500 g

1 kg

8.1517.5029.8049.65

[58-08-2](1,3,7-Trimethylxanthine)MonohydrateProtects against virus induction andchemical carcinogenesis.Ref.: Rothwell, K., (1974), Nature, 252,69-70; Yosh-Kura, H., (1974), Nature, 252,71.C8H10N4O2 • H2O MW 212.2

150114 RT

CAFFEINE 100 g 250 g 500 g

1 kg

13.9527.9046.5077.40

[58-08-2](1,3,7-Trimethylxanthine)AnhydrousC8H10N4O2 MW 194.2

150545 0oC

CALCINEURIN 50 U 100 U

171.00332.00(Calmodulin binding protein)

(Modulator binding protein)From Bovine BrainLyophilized powder containing approx. 1%protein (Lowry) the balance primarilybuffers, salts and stabilizers.Unit Definition: One unit will cause 50%inhibition of the activatedphosphodiesterase 3′-5′ cyclic nucleotideactivity when assayed in two units ofactivator and 0.1 mM Ca2+ in an enzymecoupled system.

190074 RT

CALMIDAZOLIUM 5 mg10 mg25 mg

40.0070.00

163.00[57265-65-3](Compound R24571, [1-bis-p-chlorophenyl)methyl]-3-[2,4-dichloro-β-(2,4-dichlorobenzyloxy) phenyl]-imidazolium chloride)Calmidazolium inhibits the Ca2+ calmodulindependent PDE. Approx. 500 times morepowerful than trifluoperazine.Ref.: Van Belle, H. (1981) in "Cell Calcium"2, 483-494.C31H23Cl7N2O MW 687.7

195691 -20oC

CALMODULIN 1 mg 154.00[73298-54-1](Phosphodiesterase 3,5′-cyclic-NucleotideActivator)From Bovine BrainPurity: ≥≥≥≥99%Lyophilized with 1.7 mM HEPES, pH7, 30µM CaCl2Activity: 13,000 units/mgUnit Definition: one unit will activate3′,5′-cyclic-nucleotide phosphodiesteraseto 50% Vmax. It may be used to activateCaM-dependent phosphodiesterase,calcineurin, CaM Kinases, etc.MW 16.7 kDa

195692 -20oC

CALMODULIN 1 KU5 KU

25 KU100 KU

13.6521.0092.00

350.00

[73298-54-1](Phosphodiesterase 3,5′-cyclic-NucleotideActivator)From Bovine BrainPurity: ≥≥≥≥98%Lyophilized virtually salt free.Activity: >40,000 units/mgUnit Definition: one unit will activate 0.016units of 3′,5′-cyclic-nucleotidephosphodiesterase to 50% Vmax whensaturated with activator in the presence of0.01mM Ca2+. It may be used to activateCaM-dependent phosphodiesterase,calcineurin, CaM Kinases, etc.

195696 -20oC

CALMODULIN 1 KU5 KU

25 KU

10.5021.3556.60

[77107-46-1](Phosphodiesterase 3,5′-cyclic-NucleotideActivator)From Porcine BrainPurity: ≥≥≥≥95%Lyophilized virtually salt free.Activity: >40,000 units/mgUnit Definition: one unit will activate 0.016units of 3′,5′-cyclic-nucleotidephosphodiesterase to 50% Vmax whensaturated with activator in the presence of0.01mM Ca2+. It may be used to activateCaM-dependent phosphodiesterase,calcineurin, CaM Kinases, etc.

195894 0-5oC

CALMODULIN 1 mg 183.00(Phosphodiesterase 3,5′-cyclic-NucleotideActivator)Chicken, RecombinantExpressed in E. coliPurity: ≥≥≥≥95%Activity: will activate nitric oxide synthase.MW 16,700

657821 -20oC

CALMODULINPOLYCLONAL ANTIBODY

1 ml 220.75

Anti-BovineHost: goatForm: delipidized pooled antiserumConc/Titer: 1:100Applications: Western BlotThe antiserum was produced in goats byinoculation with of purified bovine braincalmodulin. Calmodulin is a small Ca2+binding protein with a molecular weight of17,000 daltons, identified in all animal andplant cells that have been examined. It isinvolved in the control of a large number ofcellular metabolic reactions and manyprocesses associated with the cytoskeletalcontractile apparatus such as the control ofmyosin light chain kinase activity whichregulates myosin contraction in smoothmuscle and non-muscle cells.

CALMODULIN-DEPENDENT PROTEIN KINASESUBSTRATESee: Syntide 2

195895 -70oC

CALMODULIN DEPENDENT PROTEINKINASE II-αααα

250 U 1 KU

25.2073.50

(CaM Kinase II)Rat, Recombinantαααα-SubunitInvolved in modulating neurite outgrowth ofthe cAMP system.Activity: 250,000 units/mlUnit Definition: one unit will catalyze thetransfer of 1 pmol of phosphate toKRQQSFDLF per minute at 30°C, pH 7.5.MW 33 kDa




159561 0oC

CALMODULIN-DEPENDENTPROTEIN KINASE II (281-309)

100 µg 90.55

Met-His-Arg-Gln-Glu-Thr-Val-Asp-Cys-Leu-Lys-Lys-Phe-Asn-Ala-Arg-Arg-Lys-Leu-Lys-Gly-Ala-Ile-Leu-Thr-Thr-Met-Leu-AlaPotent inhibitor of calmodulin-dependentprotein kinase II.Ref.: Colbran, R.J., et al., J. Biol. Chem.,208, 18145 (1988).

159562 0oC

CALMODULIN-DEPENDENTPROTEIN KINASE II (290-309)

100 µg 59.65

[115044-69-4]Leu-Lys-Lys-Phe-Asn-Ala-Arg-Arg-Lys-Leu-Lys-Gly-Ala-Ile-Leu-Thr-Thr-Met-Leu-AlaInhibitor of Ca2+/Calmodulin-dependentprotein kinase IIRef.: Payne, M.E., et al., J. Biol. Chem.,263, 7190 (1988).

158834 0-5oC

CALPAIN INHIBITOR I 1 mg5 mg

10 mg

13.7557.35

103.20[110044-82-1](N-Ac-Leu-Leu-Norleucinal)Purity: 98%An inhibitor of both Calpain I and II(calcium-dependent cysteine proteases).Has been reported to be useful in the studyof cytoskeletal and muscle protein turnover.Ref: 1) Murachi, T., Trends Biochem. Sci.,8, 167 (1983). 2) Yoshimura, et.al., J. Biol.Chem., 258, 8883 (1983).MW 383.5

158835 0-5oC

CALPAIN INHIBITOR II 1 mg5 mg

10 mg

13.7557.35

103.20[136632-32-1](N-Ac-Leu-Leu-Methioninal)Purity: >98%An inhibitor of both Calpain I and II(calcium-dependent cysteine proteases).Has been reported to be useful in the studyof cytoskeletal and muscle protein turnover.Ref: 1) Murachi, T., Trends Biochem. Sci.,8, 167 (1983). 2) Yoshimura, et.al., J. Biol.Chem., 258, 8883 (1983).MW 403.6

159563 0oC

CALPEPTIN 5 mg10 mg

72.00131.00[117591-20-5]

(N-CBZ-L-Leucyl-Norleucinal)Inhibitor of Calpain and Cathepsin L.Ref.: Sasaki, et al., J. Enz. Inhib., 3, 195(1990).C20H30N2O4 MW 362.5

158882 0oC

CALPHOSTIN C 100 µg 113.95[121263-19-2](UCN-1028C)Purity: 99%From Cladosporium cladosporioidesHighly specific and potent protein kinase Cinhibitor.Ref.: 1. Kobayashi, E., et.al., J. Antibiot.,42, 1470 (1989). 2. Lida, T., et.al., ibid., 42,1475 (1989).C44H38O14 MW 790.6

158378 0-5oC

CALYCULIN A 10 µg50 µg

89.95335.65[101932-71-2]

Purity: ≥≥≥≥95%Phosphatase inhibitor with very potentinhibitory activity against both PP1 andPP2A phosphatases.IC50 values of approximately 1 nm for bothPP1 and PP2A.Ref.: 1. Ishihara, H., et.al., Biochem.Biophys. Res. Commun., 159, 871 (1989).2. Suganuma, M., et.al., Cancer Res., 50,3521 (1990).C50H81N4O15P MW 1009.18

159732 0-5oC

CAMPTOTHECIN 25 mg50 mg

100 mg250 mg

17.0030.0055.00

130.00

[7689-03-4]Purity: 97%Binds to and stabilizes thetopoisomerase-DNA covalent complexwhich reversibly inhibits nucleartopoisomerase I. Also, inhibitsTAT-mediated HIV-1 trasactivation.Ref.: 1. Hertzberg, R.P., et al., Biochem. J.,28, 4629 (1990).2. Hsiang, Y.H., et al., J. Biol. Chem., 260,14873 (1985).3. Li, C.J., et al., J. Biol. Chem., 269, 7051(1994).C20H16N2O4 MW 348.4

26027 0-5oC

CAMPTOTHECIN, [3H(G)] 1 mCi 1696.65Sp. Act. 100-500 mCi/mmol3.70-18.5 GBq/mmolSolid under argon.Please call for delivery information.MW 348.34

100186 0-5oC

L-CANAVANINE SULFATE 100 mg250 mg

1 g

10.7526.0099.85

[2219-31-0]CrystallineIsolated from Jack BeansInhibits arginine metabolism, and is asubstrate in certain transamidinationreactions. Decomposed by strong acidsand light. Soluble in chloroform, acetoneand methanol.C5H12N4O3 • H2SO4 MW 274.2

158883 -20-0oC

CANTHARIDIC ACID 5 mg10 mg

44.1583.65[28874-45-5]

C10H14O5 MW 214.2

158884 -20-0oC

CANTHARIDIN 25 mg100 mg

45.90143.30[56-25-7]

C10H12O4 MW 196.2

CAPSAICINSee: 8-Methyl-N-vanillyl-6-nonenamide

159796 RT

CAPSAZEPINE 1 mg5 mg

22.9591.70[138977-28-3]

(N-[2-(4-Chlorophenyl)ethyl]-1,3,4,5-tetrahydro-7,8-dihydroxy-2H-2-benzazepine-2-carbothioamide)A competitive antagonist for capsaicin andresiniferatoxin.C19H21N2O2SCl MW 376.9

CARBACHOLSee: Carbamylcholine Chloride

159080 -20oC

CARBACYCLIN 1 mg 258.00[69552-46-1](6α-Carba-prostaglandin I2;Carbocyclic PGI2)Purity: 99%CrystallineAnalog of prostaglandin with similar activity.C21H34O4 MW 350.5

194154 0-5oC

CARBADOX 5 g 25 g

100 g

11.0019.0055.00

[6804-07-5](3-[2-Quinoxalinylmethylene]carbazic acidmethyl ester-N,N′-dioxide)Purity: 97%C11H10N4O4 MW 262.2

100194 RT

CARBAMYLCHOLINE CHLORIDE 10 g 25 g

100 g

18.0032.00

131.00[51-83-2](Carbachol)CrystallinePurity: 99%Non-selective agonist that is resistant to theaction of cholinesterase. Inhibits apoptoticdeath of cultured granule neurons.C6H15ClN2O2 MW 182.65




150557 0-5oC

CARBETAPENTANE 250 mg1 g

49.00160.00[23142-01-0]

(1-Phenylcyclopentanecarboxylic acid2-[2-diethylaminoethoxy]ethyl ester)Citrate SaltHigh affinity agonist for sigma1 receptors.AntitussiveWhite crystalline powderC20H31NO3 • C6H8O7 MW 525.6

153757 RT

S(-)-CARBIDOPA 10 mg15 mg25 mg

100 mg

16.0020.0028.0091.25

[28860-95-9](S(-)-α-Hydrazino-3,4-dihydroxy-α-methylbenzenepropanoic acid)Used as a Parkinson’s Disease therapeuticin combination with L-DOPA.C10H14N2O4 MW 226.2

151446 0oC

(±±±±)CARBOCYCLIC THROMBOXANEA2

100 µg500 µg

57.35229.30

[74034-56-3](CTA2)Supplied as 50 µg/ml in ethanol.C22H36O3 MW 348.5

159731 RT

ββββ-CARBOLINE-3-CARBOXYLIC ACIDBUTYL ESTER

1 mg5 mg

14.3548.70

[84454-35-3]Benzodiazepine receptor ligandC16H16N2O2 MW 268.3

153715 RT

ββββ-CARBOLINE-3-CARBOXYLIC ACIDETHYL ESTER

25 mg250 mg

15.0086.75

[74214-62-3](β-CCE)Purity: 98%Inverse agonist to benzodiazepineC14H12N2O2 MW 240.3

154934 0-5oC

ββββ-CARBOLINE-3-CARBOXYLIC ACIDMETHYL ESTER

10 mg25 mg

100 mg

24.9599.75

169.50[69954-48-9](β-CCM)Benzodiazepine inverse agonistRef.: Lippke, K.P., et al., J. Med. Chem.,26, 499 (1983).C13H10N2O2 MW 226.2

153774 RT

ββββ-CARBOLINE-3-CARBOXYLIC ACIDPROPYL ESTER

10 mg15 mg25 mg

19.5527.3543.35[76808-18-9]

(β-CCP)Benzodiazepine inverse agonistC15H14N2O2 MW 254.3

159735 0oC

N-CARBOMETHOXYCARBONYL-D-PRO-D-PHE BENZYL ESTER

1 mg5 mg

25 mg

11.4528.10

112.35[129988-00-7](Harvard Peptide)Blocks gp120 binding to CD4 glycoprotein.Reported to inhibit infection by HIV.Ref.: Finberg, R. W., et al., Science, 249,287 (1990).C24H26N2O6 MW 438.5

159736 0oC

N-CARBOMETHOXYCARBONYL-PRO-PHE BENZYL ESTER

1 mg5 mg

13.7555.00

Blocks gp120 binding to CD4 glycoproteinand inhibits HIV infection, but is less activethan the D-isomer peptide.Ref.: Finberg, R.W., et al., Science, 249,287 (1990).C24H26N2O6 MW 438.5

153756 -20-0oC

5-CARBOXAMIDOTRYPTAMINEMALEATE

1 mg5 mg

17.0072.00

[74885-09-9]5-HT1 serotonin receptor agonistC11H13N3O • C4H4O4 MW 319.3

159564 0-5oC

1-(7-CARBOXYHEPTYL)IMIDAZOLE 5 mg25 mg

34.40149.05Hydrochloride

Selective thromboxane synthetase inhibitor.Ref.: Kayama, et al., Prostaglandins, 21,543 (1981)C11H8N2O2 • HCl MW 246.7

196051 -20oC

1-[2-(CARBOXYLATO)PYRROLIDIN-1-YL]DIAZEN-1-IUM-1,2-DIOLATEMETHANOL

1 mg5 mg

25 mg

10.5027.3099.75

(PROLI NONOate, PROLI/NO)Disodium SaltPurity: ≥≥≥≥98%A nitric oxide donor.Ref.: Saavedra, J.E., et al., Jour. of Med.Chem., 39(22), 4361-4365 (1996).C5H7N3O4Na2 MW 251.1

159740 RT

(±±±±)-3-CARBOXYPHENYLGLYCINE 1 mg5 mg

10 mg

21.4586.00

155.90[2196-57-8]C9H9NO4 MW 195.2

158885 RT

(±±±±)-3-(2-CARBOXYPIPERAZIN-4-YL)-PROPYL-1-PHOSPHONIC ACID

5 mg 72.80

[100828-16-8](CPP)Purity: 98%Strong NMDA antagonist.Ref.: Davies, J., et.al., Brain Res., 382, 169(1986)C8H17N2O5P MW 252.2

196042 RT

R-(-)-3-(2-CARBOXYPIPERAZIN-4-YL)-PROPYL-1-PHOSPHONIC ACID

1 mg5 mg

29.95118.50

[126453-07-4](D-CPP; R-CPP)Purity: ≥≥≥≥98%Potent and selective NMDA antagonist.Ref.: Chapman, A.G., et.al., Eur. Jour. ofPharmacol., 178(1), 97-99 (1990)C8H17N2O5P MW 252.2

159815 0-5oC

CARBOXY-PTIO 1 mg5 mg

25 mg

11.7530.00

120.00[148819-94-7](2-(4-Carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide)Potassium SaltNitric Oxide radical scavenger withantagonistic action against the NO freeradical.Ref.: Akaike, T., et al., Biochemistry, 32,827 (1993).C14H16N2O4K MW 315.4

153548 RT

CARISOPRODOL 250 mg1 g

7.0015.00[78-44-4]

(1-Methylethyl)carbamic acid2-[[(aminocarbonyl)oxy]-methyl]-2-methylpentyl ester)C12H24N2O4 MW 260.3

152944 -20-0oC

αααα-CASEIN, Fragment 90-95 1 mg 30.30[83471-50-5](Arg-Tyr-Leu-Gly-Tyr-Leu)Ref: Loukas, S., et al., Biochemistry, 22,4567 (1983).C38H57N9O9 MW 783.9

152945 -20-0oC

αααα-CASEIN, Fragment 90-96 1 mg5 mg

35.

Documents

Neuroscience Products - ziobio › ICN PDF › neurocatalog › neurocatalog.pdfCATALOG CATALOG NUMBER U.S. $ NUMBER U.S. $ Neuroscience Products One call. One source. 1147 To place